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Differential Coupling of RGS3s and RGS4 to GPCR-GIRK
Channel Signaling Complexes
Cristina Jaén

ABSTRACT

‘Regulators of G protein signaling’ (RGS proteins) modulate the G protein
cycle by enhancing the GTPase activity of Gα subunits. These changes
accelerate the kinetics of ion channel modulation by Gαi/o-coupled receptors
(GPCRs) such as the G protein-gated inward rectifier K+ (GIRK/Kir3) channel. My
experiments indicate that a single cerebellar granule (CG) neuron, a cell type that
endogenously expresses GIRK channels is able to express a wide variety of
RGS proteins. I selected two of them, which are widely expressed and
transcriptionally regulated during pathophysiologic conditions, to compare their
functional properties. I originally described the differential modulatory effects of
two RGS proteins, the RGS3 short isoform (RGS3s) and RGS4, on muscarinic
m2 and serotonin 1A receptor-coupled Kir3.1/Kir3.2a channels expressed in
Chinese hamster ovary (CHO-K1) cells. Both RGS3s and RGS4 accelerated
GIRK activation and deactivation current kinetics in a similar way. However, only
RGS3s significantly decreased the maximal GIRK current (Imax) elicited by ACh
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(~45% inhibition) and significantly increased the EC50 for both GPCRs. The
hypothesis that emerged from this initial study was that the distinct RGS4 Nterminal domain mediated a direct coupling of RGS4 to GPCR-GIRK channel
signaling complexes that was not shared by RGS3s. To test this hypothesis, I
epitope-tagged several GPCRs, the Kir3.1 subunit, RGS3s, RGS4, and several
deletion mutants and chimeras for co-immunoprecipitation experiments. Using an
epitope-tagged degradation resistant RGS4 mutant RGS4(C2V), I detected coprecipitation of different GPCR-GIRK channel complexes with RGS4 but not
RGS3s.
The functional impact of RGS4 coupling to the GPCR-Kir3 channel
complex versus uncoupled RGS3s was not apparent in recordings from CHO-K1
cells presumably due to a high degree of RGS collision-coupling. Controlled
expression in Xenopus oocytes revealed a 30-fold greater potency for RGS4 in
the accelerating GIRK channel gating kinetics.
In summary, these findings demonstrate that one of the ways for the cell
to achieve signaling pathway specificity may be through selective coupling of the
different GPCR-effector-RGS protein complexes.
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CHAPTER 1
INTRODUCTION AND BACKGROUND

G protein coupled receptors (GPCRS)
G-protein coupled receptors (GPCRs) are transmembrane receptors that
mediate most of their intracellular actions through pathways involving activation
of G-proteins. GPCRs have an extracellular N terminus, a cytoplasmic C
terminus and 7 transmembrane α−helices connected by three intracellular loops
and three extracellular loops. They are also called heptahelical receptors or
serpentine receptors. The extracellular receptor surface is critical for ligand
binding and the intracellular surface is involved in G-protein recognition and
activation (Wess, 1997). GPCRs are some of the oldest receptors devoted to
signal transduction present throughout the evolutionary process, they appear in
plants, yeast, slime mold, protozoa, diploblastic metazoa as well as vertebrates
(Bockaert and Pin, 1999).The superfamily of GPCR is the largest gene family
found so far, more than 1000 human genes have been identified for GPCRs,
which include the m2 muscarinic receptor, the serotonin 1A receptor, the α2
adrenergic receptor, the D2-dopaminergic receptor, the opioid receptors, the A1
adenosine receptor, the lysophosphatidic acid 1 receptor, and the gamma-
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aminobutyric acid type B (GABAB) receptor. GPCRs have a wide variety of
ligands such as small biogenic amines (for example, 5-hydroxytryptamine (5-HT),
dopamine, acetylcholine, epinephrine/norepinephrine, histamine), hormones,
chemokines,

local

mediators,

the

amino

acid

L-glutamate,

peptides,

polypeptides, nucleotides, prostanoids, calcium ions, and lipids. GPCRs also play
fundamental roles in sensory systems mediating vision, smell, and taste by
responding to light, odorants, and taste stimuli (Wess, 1998). It has been
estimated that about 80% of known hormones and neurotransmitters activate
cellular signal transduction mechanisms through GPCRs (Birnbaumer 1990), and
GPCRs represent 30-45% of current drug targets (Drews et al., 2000; Hopkins
and Groom, 2002). GPCRs are susceptible to post-translational modifications,
they can be palmitoylated, phosphorylated, and glycosylated. All of these
modifications are important for the proper channel function, mediating trafficking,
desensitization, and coupling (Daaka et al., 1997; Duvernay et al., 2005; Qanbar
and Bouvier, 2003).
GPCRs show selective coupling to G-proteins, for example, muscarinic
m1, m3, and m5 couple to the Gq/G11 family of G-proteins whereas m2 and m4
subtypes preferentially interact with the Gi/o family (Gainetdinov and Caron,
1999; Offermanns et al., 1994). Recent studies are challenging the classical idea
that GPCRs act as monomers, and the stoichiometry is one receptor and one G
protein coupling. Now it seems that a stoichiometry of 2 GPCRS and 1 G protein
is more correct (Bulenger et al., 2005). Not only homo-heteromerization of
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GPCRs is important and necessary for receptor trafficking and maturation, but it
seems to be important for receptor selectivity as well. Chemokine receptors can
form homo- and heterodimers. Depending on their composition they activate
either Gi signaling pathway (homodimers) or Gq/11 (heterodimers) (Mellado et
al., 2001). The diversity and physiological importance of GPCRs are increasing
due to splice isoforms from already characterized GPCRs that show differential
tissue specificity (Cole and Schindler, 2000; Huang et al., 2004; Mohler et al.,
2001; Zhang et al., 2004).

Guanine nucleotide-binding proteins (G proteins)
Heterotrimeric guanine nucleotide-binding proteins (G proteins) are
composed of α, β and γ subunits. They transduce extracellular signals received
by 7-transmembrane receptors into intracellular signals through effector
activation (Neer, 1995). Upon GPCR activation, the α subunit of the G protein
exchanges its bound GDP for GTP. This causes the βγ subunit to dissociate from
the Gα−GTP subunit, and either Gα−GTP or Gβγ or both act as downstream
effectors in enhancing the receptor-mediated signal. The duration of G-protein
coupled signaling is controlled by the lifetime of GTP-bound Gα subunit.
Termination of the G protein cycle occurs when the intrinsic GTPase activity of
the Gα subunit hydrolyzes the GTP and Gα-GDP reassociates with its Gβγ
subunit (Sadja et al., 2003). Mammalian genes for 16 Gα, 5Gβ, and 12 Gγ
subunits have been identified, as well as many splice variants for these genes
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(Downes and Gautam, 1999). G proteins are divided into four families based on
their Gα subunit: Gs, Gi/o, Gq/11 and G12/13. The Gi/o group is composed of three
distinct αi (αi1, αi2 and αi3), two splice forms of αo (αoA and αoB), two splice forms
of αt, αgust and αz (Wess, 1998). The different Gα subunits are determinant for
receptor coupling specificity. For example serotonin 1A, 1B, and muscarinic m2
receptors can couple with Gi1 but not Gt, meanwhile adenosine A1 receptor can
couple to both of them (Slessareva et al., 2003).
The Gs subunit stimulates adenylyl cyclase (AC) increasing the
intracellular concentration of cyclic adenosine-3’,5’-monophosphate (cAMP). Gq
subunit activates phospholipase C-β (PLC-β) catalyzing hydrolysis of the
phosphatidylinositol 4,5-bisphosphate (PIP2) to form second messengers, inositol
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). The Gi/o subunits have
several functions: Gt1 activates cGMP phosphodiesterase, Go modulates Ca2+
channel function, and Gi subtypes inhibits AC (Cabrera-Vera et al., 2003).
Initially, Gβγ subunits were thought to be as passive elements just binding
to Gα subunits. Now it is known that Gβγ regulate several effectors such as K+
and Ca2+ channels, PLCβs, and PI3 kinase (Cabrera-Vera et al., 2003).

Regulator of G protein signaling (RGS) proteins
Regulators of G protein signaling (RGS) proteins speed up passage
through the G-protein cycle by increasing the intrinsic GTPase activity of Gα
subunits, thereby accelerating the reassociation of the ‘inactive ’heterotrimeric
4

complex Gα(GDP)βγ (Ross and Wilkie, 2000). RGS proteins are characterized by a
highly conserved ‘RGS domain ’of ~ 125 a.a. that confers direct binding to
Gα subunits and is flanked by less conserved N- and C-terminal domains of
variable length (Tesmer et al., 1997). The first mammalian RGS proteins were
reported about ten years ago (Druey et al., 1996; Vries et al., 1995). More than
20 mammalian RGS genes have been identified to date and are classified into
six subfamilies (RZ, R4, R7, R12, RA, RL) based on sequence homology within
the RGS domain (Hollinger and Hepler, 2002; Ross and Wilkie, 2000).
Alternative splice isoforms from the already characterized RGS proteins
have been described, some of them having specific functions (Hollinger and
Hepler, 2002). Thus far, there are four RGS3 splice isoforms that differ in their Nterminal domain: C2PA-RGS3, the largest one (Kehrl et al., 2002). PDZ-RGS3,
that binds through the PDZ domain to the Ephrin B receptor and through the
RGS domain regulates the migration response of cerebellar granule cells
mediated by SDF-1 chemoattractant (Lu et al., 2001). RGS3T is a truncated form
of RGS3, it is localized at the nuclear level and is involved in apoptosis (Dulin et
al., 2000). And RGS3s “short” is highly expressed in heart, brain and lungs, and
inhibits chemotactic responses of B lymphocytes (Reif and Cyster, 2000).
RGS proteins show distinct tissue distribution (Gold et al., 1997; GrafsteinDunn et al., 2001), they also have specificity towards Gα subunits. For example
RGS9 interacts with Gt, meanwhile RGS4 interacts with Gi/o and Gq. RGS2
interacts preferentially with Gq (Hollinger and Hepler, 2002).
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RGS

proteins

can

be

phosphorylated

and

palmitoylated,

these

posttranslational modifications produce a variety of effects including alterations in
subcellular localization, protein stability and alterations in GAP activity (Riddle et
al., 2005)
Originally RGS proteins were thought to be only GTPase-activating
(GAPs) proteins. However, increasing evidence is pointing to a bigger role in
signal transduction. Some RGS are able to interact with other proteins via nonRGS domains, such as RGS12 that with the PDZ domain binds to IL-8 receptor
and through its PTB domain is able to bind to N-type Ca2+ channels. PDZ-RGS3s
binds via the PDZ domain the Eprin B receptor. RGS3 and RGS7 can bind 14-33 proteins when phosphorylated (Hollinger and Hepler, 2002). RGS4 appears to
regulate Gα function based in recognition of receptors rather than association
with Gα. In pancreatic acinar cells carbachol, bombesin, and cholecystokinin
(CCK) activate Gq/11 pathways via specific GPCRs. Deletion of the RGS4 Nterminus eliminated the receptor selectivity and reduced the potency of the
inhibition (Zeng et al., 1998). In another study, RGS1 and RGS16 also displayed
receptor selectivity, whereas RGS2 displayed no preference among the three
receptors (Xu et al., 1999). In striatum, RGS9-2 modulates Ca2+ channel
inhibition in a GPCR specific manner (Cabrera-Vera et al., 2004).
RGS proteins are emerging as attractive therapeutic targets (Hollinger and
Hepler, 2002; Neubig and Siderovski, 2002; Riddle et al., 2005; Zhong and
Neubig, 2001). RGS2 appears to be linked to cardiovascular diseases. RGS2
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knockout mice exhibit a severe cardiovascular phenotype (Heximer et al., 2003),
and overexpresion of RGS2 is seen in individuals with Bartter’s/Gitelman’s
Syndrome (Calo et al., 2004). RGS4 has been linked to schizophrenia (Chowdari
et al., 2002; Mirnics et al., 2001). In addition, an RGS9 mutation has been
identified as the cause of a pathological condition, where patients with mutations
in either RGS9-1 or R9AP (RGS9 anchor protein) have slow photoreceptor
deactivation and difficulty in adjusting to changes in light levels, as well as in
seeing low-contrast moving objects (Nishiguchi et al., 2004).

G protein coupled inward rectifying potassium (GIRK) channel
G protein-gated inward rectifying potassium (GIRK) are selective K+ ion
channels “opened” by a direct interaction with Gβγ subunits (Logothetis et al.,
1987). GIRK channels belong to the K+ inward rectifier (Kir) channel family, that
is divided into 6 main subfamilies (Kir1.0-kir6.0), so they can also be named Kir3
channels (Doupnik et al., 1995). This family is characterized for having “inward
rectification” which means that these channels allow potassium ions to flow
through them more readily into the cell than out of the cell at hyperpolarized
membrane potentials (Hille, 2001). GIRK channels are activated by GPCRs that
couple to Gαi/o (Dascal, 1997) and inhibited by receptors that couple to Gαq (Lei
et al., 2001). A large number of agonists can activate GIRK channels through
Gi/o receptors such as acetylcholine (Dascal et al., 1993), adenosine (Leaney
and Tinker, 2000), dopamine (Inanobe et al., 1999; Leaney and Tinker, 2000),
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GABA (Leaney and Tinker, 2000), serotonin (Dascal et al., 1993; Karschin et al.,
1991), norepinephrine (Lim et al., 1995; Mullner et al., 2000), somatostatin
(Takano et al., 1997), and LPA (Itzhaki Van-Ham et al., 2004) The activation of
these channels by PTX-sensitive G protein coupled receptors cause membrane
hyperpolarization. The physiological role of GIRK channels is to maintain the
resting membrane potential near the potassium equilibrium potential, and to slow
pacemaker action potential frequency and heart rate (Breitwieser and Szabo,
1985; Kurachi et al., 1986; Logothetis et al., 1987; Pfaffinger et al., 1985). They
are also involved in the slow phase of inhibitory postsynaptic potentials (Doupnik
et al., 1995; Luscher et al., 1997; Nichols and Lopatin, 1997; Stanfield et al.,
2002). The sequestration of Gβγ by GDP-bound Gα subunit will close the
channel. The kinetics of activation and deactivation of GIRK channels therefore
reflect the kinetics of the G protein cycle.
The properties of GIRK channel gating can be modulated by a variety of
factors such as phosphatidylinositol-4,-5-biphosphate (PIP2), Na+, Mg2+,
oxidation-reduction, phosphorylation, and acidification (Sadja et al., 2003).
Four GIRK subunits have been found in mammals (GIRK1,2,3,4 or
Kir3.1,2,3,4), another subunit GIRK5 has been characterized in Xenopus oocytes
(Yamada et al., 1998). Furthermore, Kir3.2 has at least three different isoforms
generated by alternative splicing named Kir3.2a, Kir3.2b, and Kir3.2c (Wei et al.,
1998). Each GIRK subunit has intracellular N and C termini, two transmembrane
domains and one “P-loop” that is considered the K+ channel “signature
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sequence” (Hille, 2001). Functional GIRK channels are heterotetramers.
Neuronal GIRK channels are composed of Kir3.1, Kir3.2, Kir3.3 subunits,
whereas cardiac channels are formed by Kir3.1 and Kir3.4 subunits. GIRK1/2
was found to be the dominant heterotetramer mainly detected in brain (Kofuji et
al., 1995; Liao et al., 1996). Only GIRK1 and GIRK4 subunits are distributed in
atrial and sinoatrial node cells of the heart (Krapivinsky et al., 1995a), which are
involved in the regulation of heart rate (Mark and Herlitze, 2000).

Coupling of GPCRs to G proteins and GIRK channels
This cartoon depicts the signaling pathway that couples GPCRs with GIRK
channels.

Upon GPCR activation, the αi/o subunit of the G protein exchanges its
bound GDP for GTP. This causes the βγ subunit to dissociate from the Gα−GTP
subunit, and bind to the GIRK channel, opening the channel and allowing K+ to
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flow out of the cell and hyperpolarizing the membrane potential. The duration of
G protein coupled signaling is controlled by the lifetime of GTP-bound Gα
subunit. Termination of the G protein cycle occurs when the intrinsic GTPase
activity of the Gα subunit hydrolyzes the GTP, and Gα-GDP reassociates with its
Gβγ subunit. RGS proteins speed up the termination of the G protein signal by
enhancing the intrinsic GTPase activity of the Gαi/o subunit, therefore accelerating
the closing of the GIRK channel.
Based on functional findings, a model that postulated the assembly of m2,
RGS4, G protein and GIRK channel was proposed (Doupnik et al., 1997; Zhang
et al., 2002). Recently, it has been shown that several GPCRs such as dopamine
2, dopamine 4 and beta2 adrenergic receptors form stable complexes with Kir3
channels in COS-7 and HEK 293 cells and brain tissue (Lavine et al., 2002).
Some in vitro experiments indicate that RGS2 is able to bind to the third
intracellular loop of the Gq/11-coupled m1 muscarinic receptor (Bernstein et al.,
2004).
My work described here confirms the existence of these supracomplexes
composed of GPCR-G protein-RGS4-GIRK channels, indicating that indeed RGS
proteins are more than simply GAPs and serve as anchoring proteins in the
assembly of these signaling complexes.
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CHAPTER 2
GENERAL METHODS AND MATERIALS

Cerebellar granule neuron cultures
Cerebellar granule (CG) neurons from neonatal rat pups were both
amiable

to

enzymatic

isolation

and

primary

culture

for

experimental

manipulations. To isolate and culture postnatal day 4–6 rat CG neurons, I used a
protocol modified from (Slesinger and Lansman, 1991). Following ip injection of
sodium pentobarbital (4 mg/100 g body weight) to induce deep anesthesia, rat
pup cerebella (2–4) were removed rapidly and placed in a 35-mm culture dish
containing ice-cold calcium and magnesium-free (CMF) Tyrode’s solution (in
mM): 136.9 NaCl, 5.4 KCl, 6.0 NaHCO3 , 0.33 Na2HPO4 , 5.5 D-glucose, 5.0
HEPES, at pH 7.4 (NaOH), containing 100 U/ml penicillin and 0.1 mg/ml
streptomycin. The tissue was minced, washed with CMF Tyrode’s solution, and
then digested with 0.5 ml of trypsin/EDTA solution (GIBCO 25300-054) for 10
min at room temperature. The digestion was stopped by placing on ice and
adding ‘‘isolation medium’’ that consisted of modified Eagle’s medium with
Earle’s salts (GIBCO 11095-080) supplemented with 10% heat-inactivated horse
serum, 25 mM KCl, 6 mg/ml d-glucose, 2 mM glutamine, 0.5 U/ml DNase I, 0.5

11

U/ml penicillin, and 0.5 g/ml streptomycin. The digested tissue was then triturated
using a 1-ml sterile pipette, and the dispersed cells plated at low density on polyl-lysine-coated 35-mm Corning cell culture dishes. The cells were incubated for 5
h at 37o in a 5% CO2 atmosphere, and then the culture medium was changed to
serum-free Neurobasal-A medium (GIBCO 10888-022) with B-27 supplement
and 25 mM KCl, 2 mM glutamine, 0.5 U/ml penicillin, and 0.5 g/ml streptomycin.
The cerebellar cell cultures were then maintained in a humidified incubator at 37o
with a 5% CO2 atmosphere for 24–48 h before extensive neurite outgrowth took
place. All procedures for the use and handling of rats were approved by our
institutional animal care and used in accordance with NIH guidelines.

Single cell harvesting for RT-PCR analysis
Single rat CG neurons were harvested from culture dishes using a
micropipette (15–30 µm tip diameter) fabricated from borosilicate glass tubes (1.5
mm outside diameter, 0.86 mm inside diameter, GC150F-10, Warner
Instruments)

by

a

programmable

microelectrode

puller

(P-97,

Sutter

Instruments). Latex gloves were worn throughout the handling and harvesting
procedure to minimize potential sources of contamination. The micropipette was
attached to a microelectrode holder used for patch-clamp recordings, allowing
application of negative or positive pressure via an attached syringe. The culture
dishes were first washed with a solution consisting of (mM) 145 NaCl, 5 KCl, 2
CaCl2 , 1 MgCl2 ,10 D-glucose, 5 HEPES, at pH 7.4 (NaOH) at room temperature
12

(~ 23oC). A single CG neuron having bipolar morphology (Fig. 3.1A) was then
drawn into the micropipette by negative pressure. The micropipettes were not
filled with solution initially, but contained 5 µl of the external solution after the cell
had been harvested. The contents of the micropipette were then expelled into a
PCR tube by positive pressure and the tube was placed on ice. For each
experiment, four to six single cells were harvested and tested in parallel with
negative and positive controls. Two negative control samples were a 5 µl sample
of RNase-free H2O and a 5 µl sample of the external solution. Positive controls
included poly(A)+ mRNA from neonatal rat whole brain (0.5–5.0 ng). Experiments
were generally repeated three times from separate dissections/ cultures for each
RGS examined to account for animal, culture, and cell variability.

Design of intron-spanning gene-specific primers
The RT-PCR approach utilizes gene-specific primers that selectively
amplify mRNA transcripts from a specific RGS gene from a single cell. Because
all mammalian RGS genes are poly-intronic (Sierra et al., 2002), intron-spanning
primers were designed

to distinguish mRNA-derived PCR products from

genomic DNA-derived products (Doupnik et al., 2001). At the time of my original
study, sequence information for rat RGS genes was limiting so mouse and
human RGS sequences were used as alternatives for primer design. The
effectiveness of each RGS primer set was confirmed by positive controls using
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samples of rat brain poly(A) mRNA. A full list of the RGS primer sequences is
provided (see Table.2.1).

Single cell reverse transcriptase PCR (RT-PCR) analysis
One-step RT-PCR was carried out using the intron-spanning gene-specific
primers according to the manufacturer’s protocol (OneStep RT-PCR, Qiagen
Inc.). For each 5 µl sample, 20 µl of a RT-PCR master mix was added and
contained the following: forward and reverse primers at 0.6 µM each (final
concentration), dNTPs at 400 µM each (final concentration), Omni-script and
Sensiscript reverse transcriptases, HotStar Taq DNApolymerase, RNase
inhibitor, and a buffer solution containing Tris–Cl, KCl, (NH4)2SO4 , MgCl2 , and
dithiothreitol. Concentrations of enzymes and buffer components were as
recommended by the manufacturer (1X concentration, Qiagen, Inc.) and included
the 1X ‘‘Qsolution,’’ which effectively reduced nonspecific bands produced by
mispriming events. Each 25 µl sample was then placed in a PCR thermocycler
(GeneAmp 2400, PE Biosystems, Inc.) for the following temperature protocol: 50o
for 30 min (reverse transcription), 95o for 15 min (activation of HotStar Taq
polymerase), 45 cycles of 94o for 30s (melt), 3–4o below the primer annealing
temperature for 30s, and 72o for 60–90s (extension). At the end of the cycling
period, samples were held at 72o for 10 min (final extension) and the reaction
was stopped by cooling to 4o. According to the manufacturer (Qiagen Inc.), this
PCR cycling protocol (45–50 cycles) was expected to allow detection of mRNA
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transcripts in the general range of 10 to 100 copies per cell. The PCR samples
were then analyzed by 2% agarose gel electrophoresis, and the products were
visualized by ethidium bromide staining and UV illumination. Gel images were
captured using a digital gel-imaging system (BioImager, Genomic Solutions Inc.)
and were scored for positive or negative expression based on visual detection of
the expected gel band.
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cDNA

Genbank
Species Accession #

Prim er Sequence

Location
(ATG = +1)

Annealing
Tem p. (oC)

Product
Size (bp)

58

339

GIRK 2a

mouse

RGS 1

human

S59049

Forw ard 5' TTGAGTTCTGGCTGGCTTGTG 3'
Reverse 5' CTGATTTGAGGAACCTGGGATAA 3'

+296
+541

52.6

246

RGS 2

mouse

U67187

Forw ard 5' GACCCGTTTGAGCTACTTCTTG 3'
Reverse 5' CCGTGGTGATCTGTGGCTTTTTAC 3'

+126
+619

54.6

494

RGS 3L

human

U27655

Forw ard 5' TTCGCCCAGCACCCTCAAGA 3'
Reverse 5' ATGCCTGGATCGCGATGTATTCA 3'

+894
+1366

59.6

473

RGS 3

human

U27655

Forw ard 5' TCCCGGAAGAGAAAGAGCAAAAA 3'
Reverse 5' ATGCCTGGATCGCGATGTATTCA 3'

+1018
+1366

58.0

349

RGS 4

rat

U27767

Forw ard 5' TGCAGGCAACAAAAGAGGTGAA 3'
Reverse 5' CCCCGCAGCTGGAAGGAT 3'

+362
+553

55.5

192

RGS 5

mouse

U67188

Forw ard 5' AGCCGCCAGCCAAAATGTGTA 3'
Reverse 5' CAAAGCGGGGCAGAGAATCCT 3'

-14
+511

58.3

525

RGS 6

human

NM004296

Forw ard 5' GGGGCGGGACCAGTTTCTACGAT 3'
Reverse 5' CCCGCCAGCGACTTTCCCTTCT 3'

+1035
+1386

59.1

352

RGS 7

rat

AB024398

Forw ard 5' ACCCATTTCTTGTACCGCCTGACC 3'
Reverse 5' TCTGCCCTTTCTCTTTGCCTGTAG 3'

+881
+1365

57.2

485

RGS 8

rat

AB006013

Forw ard 5' GACAAACCCAACCGCGCTCTCAAG 3'
Reverse 5' CGTGGCCTCTCGGGTCTGGAAATC 3'

+106
+393

60.6

288

RGS 9

rat

AB019145

Forw ard 5' TACCGGACTGGAAAGGAGAGGAAC 3'
Reverse 5' ACCCGGTGCCAGGAACAGC 3'

+496
+1074

58.6

579

RGS 10

human

NM002925

Forw ard 5' GAGCCTCAAGAGCACAGCCAAATG 3'
Reverse 5' GCGGTTCTTCCAGGATCTTCTCGT 3'

+48
+325

56.9

278

RGS 11

mouse

AF061934*

Forw ard 5' TCAGTGCGGAAAACCTCA 3'
Reverse 5' CCGCAAGAATGGAAATG 3'

+890*
+1224*

56.1

335

RGS 12

rat

U92280

Forw ard 5' ATCGAAATGTTAGAAAGACCAAAGAGGAC+1847
3'
Reverse 5' ATGGAAAACCCGGACTTGACAGCA 3'
+2951

59.5

1105

RGS 13

human

AF030107

Forw ard 5' TCAAACGGATCATAACAAAGAGGA 3'
Reverse 5' CAAAAGACTGGGCCCACTGTAATA 3'

-180
+106

52.7

286

RGS 14

rat

U92279

Forw ard 5' TCAGCGCCGAGAATGTAACTTT 3'
Reverse 5' TGGGCCAGCACCTCCTCACTAA 3'

+266
+446

57.8

181

RGS 16

mouse

U72881

Forw ard 5' TGCCGCACCCTAGCCACCTTC 3'
Reverse 5' TTCGCTGCGGATGTACTCGTCAAA 3'

+4
+372

59.3

369

RGS 17
(RGSZ2)

mouse

AF191555

Forw ard 5' GGAAACCAAAGGCCCAACAATAC 3'
Reverse 5' ATCATCCTGGCCTTTTCTTCAACA 3'

+58
+407

57.0

350

RGS 18

mouse

AF302685

Forw ard 5' GCCAAAATCAGAGCGAAAGA 3'
Reverse 5' GTGCCGTATCAAAACTGTGGAG 3'

+109
+529

53.6

421

RGS 19
(GAIP)

rat

AF068136

Forw ard 5' ACGGGCCGCAGTGTATTCC 3'
Reverse 5' CCGGTGCATGAGGGTGTAGAT 3'

+295
+570

57.9

276

RGS 20
(RGSZ1)

mouse

NM021374

Forw ard 5' AGAAGACCAGAGACCCCAAAGAGC 3'
Reverse 5' AGTTCATGAAGCGGGGATAGGAGT 3'

+231
+664

56.6

434

Forw ard 5' CCTGCCGGGGCTGATGATGTGA 3'
Reverse 5' TTGGTCCTGTCTCGGCTGATGTGT 3'

Table 2.1 Gene Specific Primers for Single-Cell RT-PCR
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Chinese hamster ovary (CHO-K1) cells for heterologous expression
Chinese hamster ovary (CHO-k1) cells are a commonly used mammalian
expression system. CHO-K1 cells are very robust and easy to grow in culture
conditions, they also display a high cotransfrection efficiency using cationic lipidbased transfection methods, a critical attribute for reconstituting expression of
multiple protein within a single cell (Ehrengruber et al., 1998). CHO-K1 cells have
a round geometry and small size making them well suited for whole-cell patchclamp recordings (Doupnik et al., 1997; Ehrengruber et al., 1998; Jaen and
Doupnik, 2005). CHO-K1 cells do not express endogenous GIRK channel
subunits, yet they do express various GPCRs (Schonbrunn, 2004) and RGS
proteins. The endogenous expression of RGS mRNA in CHO-K1 cells has been
partially characterized (RGS1, RGS2, RGS3, RGS4, RGS10, RGS16, and
RGS19) with RGS2 being significantly expressed, RGS4 not expressed, and the
others being expressed at moderate to low levels based on RT-PCR analysis
(Boutet-Robinet et al., 2003; Takesono et al., 1999).

Heterologous expression of wild type cDNAS in CHO-K1 cells
CHO-K1 cells (American Type Culture Collection, Manassas, VA) were
cultured in α-modified Eagle’s medium containing 5% fetal bovine serum and 0.1
mg/ml streptomycin, and maintained in a humidified 5% CO2 incubator at 37 oC.
One day after low density plating in 35 mm dishes, cells were transfected with
DNA-liposome complexes composed of lipofectamine (Invitrogen, Carlsbad, CA)
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and a mixture of cDNAs cloned into the mammalian expression vector
pcDNA3.1(+) (Invitrogen). The total DNA (µg) to lipofectamine (µg) ratio was kept
constant at 1:5 when pre-forming the DNA-liposome complexes. The amount of
each DNA vector in the mixture per dish was as follows; 0.2 µg rat Kir3.1
(GenBank accession # NM_031610), 0.2 µg mouse Kir3.2a (GenBank accession
# NM_010606), 0.2 µg GPCR either human muscarinic m2 receptor (GenBank
accession # NM_000739) or human 5-HT1A receptor (GenBank accession #
NM_000524), with or without 1.0 µg RGS either mouse RGS3s (GenBank
accession # NM_134257) or rat RGS4 (GenBank accession # NM_017214), with
0.1 µg enhanced green fluorescent protein (GFP) cDNA (pGreenlantern-1,
GIBCO) included as a reporter gene (Doupnik et al., 1997; Doupnik et al., 2004).
The transfected cells were incubated overnight in serum-free OPTI-MEM media
(Invitrogen). Twenty-four to thirty-six hours after transfection, single GFP-positive
cells were selected for electrophysiological recordings. The RGS3s cDNA clone
was generously provided by Drs Karin Reif and Jason Cyster (University of
California, San Francisco) (Reif and Cyster, 2000). All other cDNA clones were
as described elsewhere (Doupnik et al., 1997; Doupnik et al., 2004). For
pertussis toxin (PTX) pre-treatment experiments, transfected CHO-K1 cells were
incubated overnight (12-18 h) with 100 ng/ml PTX (P-7208, Sigma Chemical).
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Construction of epitope-tagged expression vectors
N-terminal-tagged GPCR’s - Complimentary DNA’s encoding the human
muscarinic m2 receptor (Genbank Accession # NM_000739), human serotonin
1A receptor (Genbank Accession # NM_000524), and mouse lysophosphatidic
acid (LPA1/edg2) receptor (Genbank Accession # NM_010336) were “tagged” at
their N-termini with the hemagglutinin (HA) sequence (YPYDVPDYA). The HA
tag was preceded by a modified influenza hemaglutinin signal sequence
(MKTIIALSYIFCLVFA) for efficient membrane targeting (Guan et al., 1992). The
signal sequence and HA tag sequence were introduced by annealing two
complimentary oligonucleotide primers (Sigma-Genosys) that contained a 5’ Hind
III restriction site followed by a Kozak translation initiation sequence
(GCCGCCACC), the 16 a.a. signal sequence, the 9 a.a. HA sequence, and
finally a 3’ Xba I restriction site. The annealed duplex was then cut with Hind III
and Xba I, and cloned into the pcDNA3.1(+) mammalian expression vector
(Invitrogen). The complete coding region of the human muscarinic m2 receptor,
human serotonin 1A receptor, and mouse LPA1 receptor were then amplified by
PCR and cloned in-frame at the Xba I site of the N-terminal HA-tag pcDNA3.1(+)
vector. The cloning process resulted in two additional amino acids (SR) between
the HA tag and starting methionine of the native GPCR sequence due to the
Xba I sequence. The human adenosine A1 receptor (Genbank Accession #
AY136746),

human

dopamine

D2L

receptor

(Genbank

Accession

#

NM_000795), and human muscarinic m1 receptor (Genbank Accession #
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AF498915) were obtained from the University of Missouri, Rolla cDNA Resource
Center (www.cdna.org) and contained N-terminal triple (3X) HA tags, and were
cloned into the pcDNA3.1(+) vector.
C-terminal-tagged Kir3 channels - The rat Kir3.1 channel subunit
(Genbank Accession # NM_031610) was tagged at the C-terminus with the MYC
epitope (EQKLISEEDL) by PCR and cloned into the pBudCE4.1 vector
(Invitrogen). The pBudCE4.1 vector is a duel expression vector where Kir3.1MYC expression was driven by the CMV promoter. Mouse Kir3.2a (Genbank
Accession # NM_010606) was cloned into the second cloning site with
expression driven by the EF-1a promoter. The Kir3.2a subunit was not modified
by epitope tagging. The resulting Kir3.1-MYC/Kir3.2a-pBudCE4.1 construct
yielded expression of both Kir3 channel subunits from a single DNA plasmid.
C-terminal-tagged RGS proteins - Rat RGS4 (Genbank Accession #
NM_017214) and mouse RGS3s (Genbank Accession # NM_134257) were
tagged at their C-termini with the FLAG epitope (DYKDDDDK) by PCR using
primers that incorporated the FLAG sequence. The RGS-FLAG constructs were
cloned into the pBudCE4.1 vector with expression driven by the CMV promoter.
Enhanced green fluorescent protein, GFP(S65T) (pGreenlantern-1, GIBCO), was
cloned into the second site with expression driven by the EF-1a promoter. The
resulting RGS-FLAG/GFP-pBudCE4.1 plasmids provided expression of the RGSFLAG protein and the GFP reporter protein from a single DNA plasmid. A
pBudCE4.1 plasmid containing only GFP(S65T) was also generated for negative
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control (RGS-) experiments. All point mutations, deletion mutations, and
chimeras of RGS3s-FLAG and RGS4-FLAG were constructed by PCR and also
cloned into the CMV promoter driven site of GFP-pBudCE4.1 vector.
The sequence of all epitope-tagged full-length cDNA constructs were
confirmed by automated DNA sequencing (Molecular Biology Core Facility,
Moffitt Cancer Center and Research Institute, Tampa, FL).

Transfection of epitope-tagged cDNAs in CHO-K1 cells
The transfection was very similar to the one previously described. In this
case, for electrophysiological experiments, cells were plated at low density on 35
mm culture dishes, and for biochemical experiments, cells were plated at a
similar density on 100 mm culture dishes.
Cells were transfected using lipofectamine (Invitrogen) and a mixture of 34 expression vectors. The total DNA (µg) to lipofectamine (µg) ratio was kept
constant at 1:5 when pre-forming the DNA-liposome complexes. The amount of
each DNA vector in the mixture for each 35 mm dish was as follows; HA-GPCRpcDNA3.1 (0.2 µg), Kir3.1-MYC/Kir3.2a-pBudCE4.1 (0.2 µg), and either RGSFLAG/GFP-pBudCE4.1 or GFP-pBudCE4.1 (negative control) (1.0 µg). For
transfection of cells plated in 100 mm dishes, the amounts were scaled 8X.
Transfected CHO-K1 cells were incubated 24-36 hr in serum-free OPTI-MEM
media (Invitrogen). For some experiments, mammalian expression vectors
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containing different Gα subunit cDNA’s (Gαi2(C352G), GαoA(C351G), or Gαq) were
included (1.6 µg for 100 mm dish).

Immunoprecipitation and co-immunoprecipitation
Transfected CHO-K1 cells (100 mm dishes) were first washed with icecold Tris Buffered Saline (TBS pH 7.2). Three 100 mm plates were combined for
each experimental condition. Cells were lysed and collected by cell scraping in
800 µl of extraction buffer at 4oC. The extraction buffer was composed of 150
mM NaCl, 50 mM Tris pH 7.5, 1 mM EDTA, 1% n-dodecyl-β-D-maltoside (MP
Biomedicals), and a protease inhibitor cocktail (Complete Mini EDTA-free,
Roche). The crude cell lysate was then left end-over-end rotating at 4oC for 30
minutes to solubilize cell membranes. Afterwards, the sample was spun for 10
minutes at 14,000 g to remove cellular debris. The protein concentrations of the
final supernatants (cell lysates) were determined using a BCA assay (Pierce).
Immunoprecipitations were

performed using anti-HA

or anti-MYC

antibodies conjugated to agarose beads (Profound IP/Co-IP kits, Pierce). Briefly,
cell lysates (~750 µl or ~600 µg) were transferred to spin columns and either
anti-HA or anti-MYC agarose beads added (10 µg) followed by end-over-end
rotation for 4 hours at 4oC. The columns were then spun to remove the cell
lysate, and the beads then washed three times with extraction buffer (500 µl
each). The immunoprecipitated proteins bound to the agarose beads were then
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eluted 3X (10 µl each) with pH 2.8 elution buffer (Pierce). The acidic protein
sample was then immediately neutralized with 1.5 µl of 1M Tris, pH 9.5.

Western blot analysis
Western blotting was performed using standard methodology. The eluted
protein samples (~30 µl) were added to 7.5 µl of a 5X SDS loading buffer (0.3 M
Tris-Cl, pH 6.8, 5% SDS, 50% glycerol, and a lane tracking dye) that also
contained β-mercaptoethanol (~10%). The samples were heated for 5 minutes at
95oC. A portion of the denatured protein sample (~20 µl) was then separated by
gel electrophoresis using 4-15% or 8-16% Tris-HCl glycine polyacrylamide gels
(BIO-RAD) and transferred to polyvinylidene difluoride (PVDF) membranes
(Immobilon-P, Millipore).
PVDF membranes were first incubated for 1 hr in blocking buffer (5%
nonfat dry milk powder in TBS with 0.05% Tween 20), then incubated overnight
at 4oC with the appropriate primary antibody; (1:1000) HRP-conjugated anti-HA
12CA5 antibody (Roche); (1:1000) HRP-conjugated anti-MYC 9E10 antibody
(Roche); (1:1000) HRP-conjugated anti-FLAG M2 antibody, or 5-10 µg/ml antiFLAG M2 antibody (F-3165 Sigma-Aldrich). For anti-FLAG immunodetection
using the non-HRP conjugated antibody (F-3165), membranes were washed in
blocking buffer (5X) and subsequently incubated for 1 hour with an HRPconjugated goat anti-mouse secondary antibody diluted 1:10,000 in blocking
buffer (sc-2318 Santa Cruz). Following all antibody incubations, PVDF
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membranes were washed 4 times (15 minutes each) with TBS containing 0.05%
Tween 20, followed by 2 times (20 minutes each) with TBS. HRPimmunoreactive

protein

bands

were

then

resolved

by

enhanced

chemiluminescence (Luminol, Santa Cruz), and detected by exposure to bluesensitive autoradiography film (Midwest Scientific). For some PVDF membranes,
antibodies were stripped and re-probed with a different antibody.

Electrophysiological recordings from cerebellar granule neurons
Critical to resolving RGS modulated GIRK current kinetics in mammalian
cells is establishing an electrophysiology setup capable of rapid solution changes
for agonist application and washout during whole-cell voltage-clamp recording. I
currently use the SF-77B Fast-Step perfusion system (Warner Instruments) that
consists of a 3-barrel array made of 700 µm square capillary tubes, delivering
gravity-driven flow of 3 independent solutions in parallel. Each barrel can receive
input via a manifold connecting up to six different solution reservoirs to expand
the solution testing capability. The movement and position of the barrel array is
computer controlled, having a limiting step-speed of ~240 ms , though can be as
fast as 120-140 ms at the highest flow rates I can generate (~75 cm column
height). These solution exchange rates are comparable to some (Breitwieser and
Szabo, 1988; Bunemann et al., 1996), though somewhat slower than the 10-50
ms time constants reported by others using similar configurations (Karschin et
al., 1991; Sodickson and Bean, 1996). Nonetheless, they are sufficient to
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temporally resolve the GIRK current kinetics observed at room temperature (2224oC) with and without RGS co-expression.

Cerebellar granule neurons are

selected for electrophysiological recordings using standard whole-cell tight-seal
patch clamp methods (Hamill et al., 1981). Cells are initially washed and placed
in an external solution that consists of (in mM); NaCl 145, KCl 5, CaCl2 2, MgCl2
1; glucose 10, HEPES 5 (pH = 7.4). After gigaseal formation and breaking into
the cell for whole-cell recording, 2 min is allowed to permit equilibration of the
intracellular solution. The composition of the internal pipette solution is (in mM):
KCl 120, NaCl 10, MgCl2 5, EGTA 1, HEPES 5, ATP 5, GTP 0.2 (pH= 7.2). First
after breaking into the cell, the membrane capacitance (a direct measure of cell
surface area) is determined via amplifier compensation, and later used to
express the maximal current amplitude as a current density (pA/pF) for cell-tocell comparisons. Agonist-evoked inward K+ currents are recorded from a holding
potential of -100 mV, which is sufficiently negative to the experimentally set K+
equilibrium potential (EK = -40 mV).
Thus after establishing the whole-cell recording and clamping the
membrane potential to -100 mV, the cell is initially superfused with a “high K+“
solution composed of (in mM): NaCl 125, KCl 25, CaCl2 2, MgCl2 1; glucose 10,
HEPES 5 (pH = 7.4). The solution is applied via one of the 700 µm square
capillary tubes positioned next to the cell and connected to a 20 ml syringe
reservoir where the flow rate is gravity controlled by adjusting the syringe height.
After a stable baseline holding current is established, the agonist is applied (in
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the high K+ solution) via the step movement of the barrel array so that agonist
flow via the adjacent barrel is positioned in line with the recorded cell. We
typically apply the agonist for 15s to minimize receptor desensitization, followed
by agonist washout with the step movement back to the high K+ solution barrel
(see Figure 2.1B). Voltage-clamp recordings are performed using an Axoclamp
1D amplifier (Axon Instruments). Current signals are sampled and digitized via a
Digidata 1200B A/D board that also synchronizes digital output signals to the SF77B Fast-step controller. Axon pCLAMP8.0 software is used to trigger the
perfusion barrel movements along with 500 ms voltage ramps (- 100 to +50 mV)
evoked before and during agonist application to assess the voltage-dependent
properties of the agonist-evoked currents. Characteristic features of GIRK
currents include steep inward rectification and K+ selectivity (i.e. a reversal
potential near the EK). The analog current signals are low-pass filtered with the
amplifier’s integrated 4-pole Bessel filter at a corner frequency of 50 Hz, and then
digitally sampled at 100 Hz. The time constants for GIRK current activation (τact)
and deactivation (τdeact) are derived by fitting a single exponential function to the
rising or decaying portion of the current (Figure 3.1D/E) using non-linear leastsquares curve-fitting software (Clampfit 8.0).

Electrophysiological recordings from CHO-K1 cells
Electrophysiological recordings from CHO-K1 cells were performed as
explained for CG granule neurons. In this case, GFP-positive cells were identified
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by epi-fluorescence microscopy using an inverted microscope (Nikon Diaphot
with CF N Plan Fluor Ph 20X objective) equipped with a mercury lamp and GFP
filter set (Endow GFP, Chroma Technology Corp.). Rapid application and
washout of different agonist (ACh or 5-HT in high K+ solution) concentrations was
performed using the multi-barrel perfusion system (SF-77B, Warner Instruments)
(Doupnik et al., 2004), see Figure 2.1A,B
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Figure 2.1. Whole cell patch-clamp recording of receptor activated GIRK
currents. (A) CHO-K1 cells twenty-four hours after DNA transfection visualized
under phase-contrast (upper panel) and

epifluorescence

(lower panel)

microscopy. Cells were transfected with EGFP, GIRK channel subunits
(Kir3.1/Kir3.2a) and the muscarinic m2 receptor. (B) Alignment and movement of
perfusion barrels for rapid solution exchange. Upper panel shows the three-barrel
array positioned with the patch clamped cell (see patch electrode) being
superfused with the high K+ solution (washing solution). Flow through both the
middle and right barrels is continuous and gravity driven. Lower panel shows the
position of the barrels following computer-controlled movement (700 µm), where
the agonist barrel is now aligned with the recorded cell.
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Electrophysiological recordings from Xenopus oocytes
All procedures for the use and handling of Xenopus laevis (Xenopus One,
Ann Arbor, MI) were approved by the University of South Florida Institutional
Animal Care and Use Committee in accordance with NIH guidelines. Oocytes
were injected with a mixture of 5’ capped cRNA’s synthesized in vitro from
linearized cDNA vectors (mMessage mMachine, Ambion). Experimental groups
(~20 oocytes each) were injected with different cRNA mixtures (50 nl final
volume) and incubated at 19oC in parallel for 48-60 hrs. All groups received
cRNA’s for the human muscarinic m2 receptor (0.5 ng/oocyte), rat Kir3.1 subunit
(0.5 ng/oocyte), and mouse Kir3.2a subunit (0.5 ng/oocyte). Expression of
RGS4(C2V)-FLAG and RGS3s-FLAG was varied by including different amounts of
cRNA (0, 0.03, 0.1, 0.3, 1.0, 3.0, 10 ng/oocyte).
ACh-activated Kir3 channel currents were recorded by two-electrode
voltage clamp methods from a holding potential of -80 mV (GeneClamp 500,
Axon Instruments). Oocytes were initially superfused with a minimal salt solution
(98 mM NaCl, 1 mM MgCl2, and 5 mM HEPES at pH 7.5), then switched to an
isotonic high K+ solution (20 mM KCl, 78 mM NaCl, 1 mM MgCl2, and 5 mM
HEPES at pH 7.5) to resolve the kinetics of ACh-activated inward Kir3 channel
currents. Rapid application and washout of ACh in the high K+ solution was
performed using a computer triggered superfusion system (SF-77B, Warner
Instruments)(Doupnik et al., 2004).

To monitor inward rectification of IK,ACh,

voltage ramps from –80 to +20 mV and 1 s in duration were evoked before and
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during agonist application. All recordings were performed at room temperature
(21-23oC).

Kinetic analysis of receptor-activated Kir3 channel currents
Time-dependent GIRK current kinetics were analyzed using nonlinear
curve fitting software that fit single exponential functions to derive activation time
constants (τact) and deactivation time constants (τdeact) (Clampfit 8.0 software,
Axon Instruments). Agonist dose-response relations were analyzed by fitting
peak GIRK current amplitudes with the Hill function, where the effective
concentration producing a 50% response (EC50) and Hill coefficient value (nH)
were derived from the best fit (Origin 6.0 software, OriginLab Corp.). For
comparison of GIRK current amplitudes across cells, agonist-evoked currents
from each cell were normalized to the measured cell membrane capacitance
(Cm) determined during capacitive current compensation. The normalized current
amplitudes are expressed as GIRK current density (pA/pF).

Statistical Analysis
Pairwise statistical analysis between experimental groups was performed
by one-way ANOVA (analysis of the variance) test where p<0.05 was considered
significant.
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CHAPTER 3
PROFILE OF RGS GENE EXPRESSION IN
CEREBELLAR GRANULE NEURONS

INTRODUCTION

G-protein-gated inwardly rectifying potassium (GIRK) channels are K+ selective ion channels ‘‘opened’’ by a direct interaction with Gβγ subunits
(Logothetis et al., 1987). Physiologically, GIRK channels play an instrumental
role in suppressing membrane excitability during the activation of G-proteincoupled receptors (GPCRs) in neurons, cardiomyocytes, and endocrine cells
(Stanfield et al., 2002; Yamada et al., 1998). Functional GIRK channels in
mammals are now known to be heterotetramers composed of Kir3.1, Kir3.2,
Kir3.3, and Kir3.4 subunits (Stanfield et al., 2002; Yamada et al., 1998). Neuronal
GIRK channels are more diverse than cardiac GIRK channels, having an
overlapping expression of Kir3.1, Kir3.2, and Kir3.3 in different regions of the
brain. Kir3 subunits 1, 2, and 3 are highly expressed in the cerebellum (Karschin
and Karschin, 1997). Furthemore, they are expressed in the distal part of the CG
neuron’s dendrites, at the level of the glomeruli where mossy fibers and
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cerebellar granule (CG) cells synapse (Ponce et al., 1996). It is also known that
expression of RGS mRNA in brain shows a distinct regional distribution detected
by in situ hybridization (Gold et al., 1997; Grafstein-Dunn et al., 2001).
Neuronal GIRK channels have only recently been studied in CG neurons,
prompted largely from the discovery of the mouse weaver gene that contains a
point mutation in the Kir3.2 subunit that disrupts K+ selectivity causing CG cell
death and phenotypic ataxia (Kofuji et al., 1996; Patil et al., 1995; Slesinger et
al., 1996; Surmeier et al., 1996). The objective of this work is to discern which
RGS genes are expressed in a CG neuron that are likely to be involved in the
modulation of endogenous CG neuron’s GIRK channels.
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RESULTS

Measuring native GIRK channel gating properties in CG neurons.
Neonatal rat CG neurons exhibited baclofen-evoked GIRK currents that
were

sustained

in

primary

culture

and

could

be

characterized

electrophysiologically (Figure 3.1). GABAB receptor-activated GIRK currents in rat
CG neurons displayed rapid activation and deactivation kinetics (Figure 3.1F)
suggesting modulation by endogenous RGS proteins.
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Fig. 3.1. Quantitative analysis of native GIRK currents recorded from rat
cerebellar granule (CG) neurons. (A) Phase-contrast image of a typical rat CG
neuron maintained in primary culture and selected for electrophysiological
recordings. (B) GABAB receptor agonist baclofen (100 µM) evoke characteristic
GIRK currents from CG neurons. Baclofen-activated GIRK currents display steep
inward rectification (C) and rapid activation (D, F) and deactivation kinetics (E, F).
Data are means ± SEM. Dashed lines in F refer to time constants for solution
exchange and represent the limit of resolving kinetic events.
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Single Cell RT-PCR analysis of Endogenous RGS Expression
To discern which RGS proteins were expressed endogenously in rat CG
neurons, single cell RT-PCR methods were developed for detecting and profiling
RGS expression in primary culture neurons. CG neurons were abundant and
could be distinguished in culture by their relative small size and simple bipolar
morphology compared to other cells present in the culture dish. Positive Kir3.2
expression in CG neurons confirmed GIRK channel expression in these cells. A
great diversity of RGS proteins expressed in the granule neurons was found. In
some cases, RGS expression was very consistent throughout the different
dissections, RGS proteins like RGS5, RGS11 and RGS9 were never detected in
the granule neurons, but others like RGS2, RGS10, RGSz2 and RGS4 were
almost always detected. However, the detection levels of others like RGS6,
RGS7 and RGS8 changed greatly from experiment to experiment, making it
difficult to extrapolate any conclusion (Fig. 3.2). GIRK2a was used as both
granule neuron marker and control of the efficacy of the sampling method (91%
efficiency). Results indicated that CG neurons expressed at least 13 different
RGS genes, and each RGS subfamily (R4, R7, R12, and RZ) was represented
(Fig 3.3). Although a profile of protein expression was not correlated with mRNA
data and relative RGS protein levels were unknown, the single cell RT-PCR
results clearly indicate that numerous RGS proteins are likely to be present in
these native GIRK-expressing cells.

36
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RGS2
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Figure 3.2. Separation of RT-PCR products by agarose gel electrophoresis. RTPCR was performed on rat CG neurons as described in the text. Results using
selected intron-spanning RGS-selective primer sets (Doupnik et al., 2001), as
well as primer sets for GIRK2 (Kir3.2a) are shown. Negative controls included
water and external solution (5 µl), and positive controls included postnatal
poly(A)+ mRNA of brain (0.5–5.0 ng). The predicted molecular size for each RGS
PCR product is indicated on the right of each gel.
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Figure 3.3. Profile of RGS expression in rat CG neurons. The percentage of cells
sampled and positive for RGS expression by RT-PCR analysis is shown for each
RGS within the R4, R7, R12, and RZ subfamilies examined. The number of cells
tested for each RGS ranges from 8 to 24 and is from at least two separate
cultures.
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DISCUSSION

My results were in agreement with published results obtained by in situ
hybridization indicating multiple RGS’s are expressed in brain (Gold et al., 1997;
Grafstein-Dunn et al., 2001). However, my data were obtained from a singular
type of cell compared to the in situ experiments where the data were obtained
from a wide variety of tissue.
I also compared the CG results with the RGS gene profile performed in rat
atrial myocytes (Doupnik et al., 2001). Both native cell systems expressed RGS
genes from each RGS subfamily (R4, R7, R12, and RZ). Intestingly, the profile of
RGS expression in cardiac myocytes and CG neurons had some differences:
there was more expression of RGS genes in CG neurons, at least 13 compared
to 7 in myocytes. Also, the percentage of some RGS expression differed
between the two cell types, for example RGS6 had an expresson of ~95% in
atrial myocytes in contrast to the ~ 30% in CG neurons. This higher expression of
RGS genes in CG neurons compared to atrial myocytes also correlated with the
τdeact of native GIRK channels recorded from both cell types, being faster in the
CG neurons (Doupnik et al., 2004).
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My data indicate that CG neurons in culture conditions express
endogenous and functional GIRK channels and that the fast τdeact observed is
likely due to the high expression of endogenous RGS.
My original goal of discerning the unique/s RGS proteins involved in the
modulation of the GIRK channels clearly was not feasible due to the great variety
of RGS proteins present in the CG neurons. For this reason, I decided to focus
my studies on two RGS proteins. I chose RGS3s and RGS4 which were
expressed in CG neurons and atrial myocytes, and performed the rest of the
experiments in an heterologous system where I could have better control of the
components of the signaling pathway.
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CHAPTER 4

NEURONAL KIR3.1/KIR3.2A CHANNELS COUPLED TO SEROTONIN 1A
AND MUSCARINIC M2 RECEPTORS ARE DIFFERENTIALLY MODULATED
BY THE ‘SHORT’ RGS3S ISOFORM

INTRODUCTION

Gβγ-gated inwardly rectifying K+ channels (GIRKs) are expressed
predominantly in brain, heart, and endocrine tissue and suppress cell excitability
during neurotransmitter and hormone activation of pertussis toxin (PTX)-sensitive
G protein-coupled receptors (GPCRs) (Stanfield et al., 2002). Consistent with
this, gene knockout of neuronal GIRK channel subunits promote spontaneous
and pharmacologically induced seizures and hyperactivity in mice (Blednov et al.,
2001; Signorini et al., 1997).The recent discovery of neuronal GIRK channel
involvement in drug-induced analgesia further highlight the physiological role of
GPCR-activated GIRK channels and their modulators in the nervous system
(Blednov et al., 2003).
The temporal gating properties of receptor-activated GIRK currents are
determined by the kinetic properties of the G protein cycle and dramatically
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accelerated by ‘regulators of G protein signaling’ (RGSs) (Breitwieser and Szabo,
1988; Doupnik et al., 1997; Saitoh et al., 1997). RGS proteins speed up passage
through the G-protein cycle by increasing the intrinsic GTPase activity of Gα
subunits, thereby accelerating the reassociation of the ‘inactive ’heterotrimeric
Gα(GDP)βγ complex (Ross and Wilkie, 2000). RGS proteins are characterized by a
highly conserved ‘RGS domain ’of ~ 125 a.a. that confers direct binding to
Gα subunits and is flanked by less conserved N- and C-terminal domains of
variable length (Tesmer et al., 1997). More than 20 mammalian RGS genes have
been identified to date and are classified into six subfamilies based on sequence
homology within the RGS domain (Hollinger and Hepler, 2002; Ross and Wilkie,
2000).
The divergent amino terminal region of the R4 subfamily of RGS proteins
has been implicated in (1) mediating RGS selective coupling to GPCRs (Zeng et
al., 1998), (2) facilitating functional α2 adrenergic receptor-GIRK channel
coupling in rat sympathetic neurons (Jeong and Ikeda, 2001), and (3) promoting
translocation of GPCR-RGS complexes to the plasma membrane (Roy et al.,
2003; Saitoh et al., 2002). Thus the divergent RGS amino terminus may provide
a means to confer selective RGS coupling to different GPCR-effector signaling
complexes (Hollinger and Hepler, 2002).
I report here the functional properties of an alternatively spliced ‘short
isoform’ of mouse RGS3 (RGS3s) (Reif and Cyster, 2000) on neuronal GIRK
channels (Kir3.1/Kir3.2a) coupled to either serotonin 1A (5-HT1A ) receptors or
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muscarinic m2 receptors in Chinese hamster ovary cells (CHO-K1). Mammalian
RGS3 isoforms are expressed in both brain and heart (Druey et al., 1996; Koelle
and Horvitz, 1996), and alternatively spliced RGS3 transcripts generate at least
four different protein isoforms having different amino terminal domains that share
a common RGS domain (Kehrl et al., 2002). The unique amino terminal region of
mouse RGS3s is 21 amino acids long and comparable in size to the 33 amino
acid N-terminus of RGS4. Yet RGS3s lacks the two Cysteines (C2 and C12) that
are conserved in some members of the R4 subfamily including RGS4 and are
susceptible to plamitoylation (Druey et al., 1999; Hiol et al., 2003; Srinivasa et al.,
1998). I therefore questioned whether the variant RGS3s isoform differentially
affects GIRK channel gating properties compared to RGS4 (Doupnik et al.,
1997). My findings demonstrate RGS3s differentially modulates GPCR-GIRK
channel complexes and suggest that different RGS N-termini may influence the
agonist sensitivity and magnitude of GIRK channel activation in a GPCRdependent manner.
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RESULTS

Properties of 5-HT1A and m2 receptor coupled GIRK currents reconstituted
in CHO-K1 cells
Co-expression of neuronal Kir3.1/Kir3.2a channels in CHO-K1 cells with
either the 5-HT1A receptor or the muscarinic m2 receptor produced agonistevoked currents that were dose-dependent and displayed strong inward
rectification (Fig. 4.1). To resolve the temporal and steady-state kinetic features
of the receptor-activated GIRK currents, 5-HT and ACh were rapidly applied and
washed out using concentrations ranging from 10-9 to 10-4 M. The reversal
potentials for the 5-HT and ACh-evoked currents were both near the
experimentally preset K+ equilibrium potential (-40 mV) consistent with K+selective GIRK channels (Fig. 4.1B). Both the 5-HT-activated GIRK currents (IK,5HT)

and Ach-activated GIRK currents (IK,ACh) displayed a similar activation and

deactivation time course following agonist washout (Fig. 4.1A). Notably, however,
the steady-state dose-dependence of 5-HT versus Ach-activated GIRK currents
indicated a significantly higher potency for 5-HT versus ACh (Fig. 4.1C). The
EC50 value for 5-HT was 24±8 nM (n=5) compared to the Ach EC50 value of
820±162 nM (n=10). This difference in EC50 values indicate either a higher

44

number of 5-HT1A receptors being expressed compared to m2 receptors and/or a
greater efficacy in 5-HT1A receptor versus m2 receptor signaling. The maximal
GIRK current density at saturating concentrations of receptor agonist (10 µM)
was comparable indicating equivalent Kir3.1/Kir3.2a channel expression with the
two GPCRs; maximal IK,5-HT 90.8±15.4 pA/pF (n=8), maximal IK,ACh 79.2±8.2
pA/pF (n=11). Other than differences in agonist dose-dependence, the temporal
kinetic features of IK,5-HT and IK,ACh were indistinguishable.
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Figure 4.1. Functional coupling of 5-HT1A receptors and muscarinic m2 receptors
to Kir3.1/Kir3.2a channels expressed in CHO-K1 cells. (A) Representative wholecell recordings from two separate cells expressing human 5-HT1A receptors
(upper trace) or human muscarinic m2 receptors (lower trace). Cells were voltage
clamped at -100 mV during a 15 s rapid application and washout of receptor
agonist (10 µM 5-HT or ACh) indicated by the horizontal bars. Voltage ramps
from -100 to +50 mV were evoked before and during agonist application to
assess the voltage dependence of the agonist-evoked currents. (B) Inward
rectification of 5-HT (open circles) and ACh-evoked GIRK currents (filled circles).
Ramp currents preceding agonist application were digitally subtracted from ramp
currents evoked during agonist application as shown in (A). Both IK,5-HT and IK,ACh
displayed strong inward rectification and reversal potentials near the predicted
Nernst potential for potassium (-40 mV). (C) Dose-response relations for 5-HT
(open circles) and ACh-activated GIRK currents (filled circles). Receptoractivated GIRK currents from varying agonist concentrations applied to the same
cell were normalized to the maximal amplitude recorded from each individual cell.
Data are the mean±SE from GFP-positive CHO-K1 cells co-transfected with
cDNA vectors encoding rat Kir3.1, mouse Kir3.2a, and either the human 5-HT1A
receptor or the human muscarinic m2 receptor, with GFP included as a reporter.
The solid curves represent Hill functions fit to the mean data points.
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-4

Effects of PTX pretreatment on 5-HT1A and m2 receptor coupled GIRK
currents
Both 5-HT1A receptors and m2 receptors are capable of coupling to all
PTX-sensitive Gαi/o subunits, and coupling in CHO-K1 cells is reportedly limited
to endogenous expression of Gαi2 and Gαi3 subunits where Gαi2 protein levels
predominate (Gαi2>>Gαi3 by 8:1) (Dell'Acqua et al., 1993; Raymond et al.,
1993). Pretreatment of cells with PTX (100 ng/ml) completely abolished the AChevoked GIRK currents (n=5) and significantly reduced the 5-HT-evoked GIRK
currents ~80% (PTX-treated 20±5 pA/pF, n=3; non-treated 94±14 pA/pF, n=8).
Thus endogenous PTX-sensitive Gαi subunits mediate the coupling of m2
receptors and 5-HT1A receptors to GIRK channels in CHO-K1 cells, although the
residual 5-HT-evoked GIRK current following PTX pretreatment may reflect a
small degree of ‘promiscuous’ 5-HT1A receptor coupling to PTX insensitive G
proteins.

Comparison of RGS3s and RGS4 effects on muscarinic m2 receptorcoupled GIRK currents
I next compared the modulatory effects of RGS3s and RGS4 on m2
receptor activated Kir3.1/3.2a channels in relation to cells that were not
transfected with exogenous RGS (control). Shown in Fig. 4.2, the activation and
deactivation kinetics of ACh-evoked GIRK currents were accelerated by either
RGS3s or RGS4 expression compared to the control cells. Kinetic analysis
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indicated RGS3s accelerated the GIRK deactivation time course somewhat
greater than RGS4 (RGS3s τdeact=0.75±0.04 s, n=8; RGS4 τdeact=1.32±G0.11 s,
n=5), although the effects of RGS3s on the GIRK activation kinetics were
equivalent to RGS4 (Fig. 4.2C). The most striking difference between RGS3s
and RGS4 was a significant reduction of GIRK current amplitude (~45%
decrease at 100 µM) and a 6-fold shift in the ACh dose-response curve
associated with RGS3s expression (Fig. 3.2D,E). With RGS3s, the Ach EC50 was
5.1±0.6 µM (n=8) compared to 0.9±0.2 µM (n=10) for control cells. By
comparison, RGS4 did not significantly affect the maximal GIRK current density
as observed previously in Xenopus oocytes (Doupnik et al., 1997), and caused a
smaller shift in the ACh EC50 value (2.0±0.5 µM, n=6) from the control group (Fig.
4.2D,E). Since the ACh dose-response curve with RGS3s expression did not
demonstrate saturation (Fig. 4.2D), GIRK current responses to 100 µM, 1 mM,
and 10 mM ACh were also compared in a separate set of cells (n=9). These
experiments confirmed that 100 µM Ach was indeed a saturating concentration,
as maximal GIRK responses to 1 mM (95±2%) and 10 mM Ach (95±2%) were
not significantly different than 100 µM ACh (93±2%). Altogether these findings
indicate RGS3s and RGS4 both accelerate GIRK channel gating kinetics, but
differentially affect steady-state m2 receptor-GIRK channel coupling properties.
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Figure 4.2. Comparative effects of RGS3s versus RGS4 on muscarinic m2
receptor-coupled Kir3.1/Kir3.2a channels expressed in CHO-K1 cells. (A)
Representative ACh-activated GIRK currents elicited from three separate
expression conditions; either without exogenous RGS expression (control
traces), with exogenous RGS4 expression (RGS4 traces), or with exogenous
RGS3s expression (RGS3s traces). GIRK currents evoked by a range of ACh
concentrations for each cell are superimposed for comparison after baseline
adjustment of the holding current immediately preceding each Ach application.
ACh applications were 15 s in duration and separated by a ~1 min washout
period. (B) Deactivation kinetics of RGS-accelerated GIRK currents. Upper
panel: deactivation time constants (τdeact) derived from control (filled bar), RGS3s
(grey bar), and RGS4 (open bar) groups following 10 µM ACh-evoked GIRK
currents. Lower panel: comparison of tdeact values following three different ACh
concentrations with either RGS3s (grey bars) or RGS4 (open bars) expression.
Data are the mean±SE where * indicates P<0.05. (C) Activation kinetics of RGSaccelerated GIRK currents. Comparison of activation time constants (τact) derived
from control (filled bar), RGS3s (grey bar), and RGS4 (open bar) groups with
increasing ACh concentrations. (D) ACh dose-response relations for control
(filled squares), RGS3s (grey triangles), and RGS4 (open circles) groups. GIRK
currents were normalized to cell membrane capacitance and expressed as a
current density (pA/pF) for group comparisons. (E) Normalized ACh doseresponse curves from data presented in (D). GIRK current amplitudes were
normalized to the maximal amplitude recorded from each cell (100 µM ACh) and
fit with a Hill function to derive EC50 values and Hill coefficients.
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Comparison of RGS3s and RGS4 effects on serotonin 1A receptor-coupled
GIRK currents
I next examined the effects of RGS3s and RGS4 on 5-HT1A-coupled GIRK
currents to determine whether the different effects of RGS3s and RGS4
observed with m2 receptor coupling were similarly conferred with 5-HT1A
receptors. Shown in Fig. 4.3, co-expression of either RGS3s or RGS4
significantly accelerated the activation and deactivation time course of 5-HTactivated GIRK currents. Kinetic analysis of both the GIRK activation and
deactivation time course indicated the accelerating effects of RGS3s and RGS4
were not significantly different from each other (Fig. 4.3B,C). Interestingly, neither
RGS3s nor RGS4 affected the maximal GIRK current density although both
appeared to have subtle effects that were not statistically significant (Fig. 4.3D).
Similar to m2 receptor coupling, RGS3s significantly shifted the 5-HT doseresponse curve yet RGS4 did not. For RGS3s, the 5-HT EC50 was 128±36 nM
(n=5) compared to 30±9 nM (n=4) for the control cells and 48±6 nM (n=9) with
RGS4 expression. Thus RGS3s, in contrast to RGS4, displays GPCR
dependence in that it dramatically reduces steady-state m2 receptor-activated
GIRK currents but not 5-HT1A receptor-coupled currents.
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Figure 4.3. Comparative effects of RGS3s versus RGS4 on serotonin 1A (5HT1A) receptor-coupled Kir3.1/Kir3.2a channels expressed in CHO-K1 cells. (A)
Representative 5-HT-activated GIRK currents elicited from three separate cell
conditions, either without exogenous RGS expression (control traces), with
exogenous RGS4 expression (RGS4 traces), or with exogenous RGS3s
expression (RGS3s traces). GIRK currents evoked by a range of 5-HT
concentrations for each cell were superimposed for comparison after baseline
adjustment of the holding current immediately preceding each agonist
application. 5-HT applications were 15 s in duration and separated by a ~1 min
washout period. (B) Deactivation kinetics of RGS-accelerated GIRK currents.
Upper panel: deactivation time constants (τdeact) derived from control (filled bar),
RGS3s (grey bar), and RGS4 (open bar) groups following 10 µM 5-HT-evoked
GIRK currents. Lower panel: comparison of τdeact values following three different
5-HT concentrations with either RGS3s (grey bars) or RGS4 (open bars)
expression. Data are the mean±SE where * indicates P<0.05. (C) Activation
kinetics of RGS-accelerated GIRK currents. Comparison of activation time
constants (τact) derived from control (filled bar), RGS3s (grey bar), and RGS4
(open bar) groups with increasing 5-HT concentrations. (D) 5-HT dose-response
relations for control (filled squares), RGS3s (grey triangles), and RGS4 (open
circles) groups. GIRK currents were normalized to cell membrane capacitance
and expressed as a current density (pA/pF) for group comparisons. (E)
Normalized 5-HT dose-response curves from data presented in (D). GIRK
current amplitudes were normalized to the maximal amplitude recorded from
each cell (10 µM 5-HT) and fit with a Hill function to derive EC50 values and Hill
coefficients.
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Effects of RGS3s and RGS4 on basal GIRK channel activity
I also analyzed the effects of RGS3s and RGS4 on receptor-independent
basal GIRK current amplitudes as reflected in the holding currents in 25 mM K+
solution. Previous reports indicate RGS3 (original 519 a.a. isoform) and RGS4
cause a significant increase in basal GIRK current activity when expressed in
either CHO or HEK293 cells by apparently increasing the availability of free Gβγ
subunits via RGS sequestration of Gα subunits (Bunemann and Hosey, 1998).
This finding is in contrast to observations in the oocyte expression system, where
RGS3 and RGS4 reduce IK,basal amplitudes by apparently shifting the equilibrium
of Gα subunits towards their GDP-bound state due to RGS-enhanced GTP
hydrolysis and effectively sequestering free Gβγ dimers that cause basal GIRK
channel activity (Doupnik et al., 1997). In the CHO-K1 experiments reported
here, expression of Kir3.1/Kir3.2a channels significantly increased the IK,basal
amplitude compared to nontransfected CHO-K1 cells (Table 4.1), thus
demonstrating a significant level of receptor-independent ‘basal’ GIRK channel
activity in the absence of exogenous RGS expression. Comparison of IK,basal
amplitudes from the control groups (RGS-) with co-expression of either RGS3s or
RGS4 did not reveal a significant difference with either m2 receptor or 5-HT1A
receptor expression (Table 4.1). Thus the effects reported by (Bunemann and
Hosey, 1998) may result from significantly higher RGS protein levels produced
with their transfection methods, since expression conditions that elevate RGS4
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levels in oocytes has also been reported to increase basal GIRK channel activity
(Keren-Raifman et al., 2001)

Table 4.1 Effects of RGS3s and RGS4 on basal GIRK channel activity in CHOK1 cells

1

Non-transfected
CHO-K1 cells
Muscarinic m2
receptor +
Kir3.1/Kir3.2a
Serotonin 1A
receptor +
Kir3.1/Kir3.2a

1

Control
-10 ± 4
(n=6)
-130 ± 17
(n=10)
-84 ± 23
(n=11)

Ik,basal (pA/pF)
PTX-treated
+ RGS3s
-

+ RGS4
-

-91 ± 16
(n=5)

-162 ± 26
(n=8)

-135 ± 23
(n=6)

-106 ± 21
(n=3)

-120 ± 31
(n=5)

-89 ± 10
(n=11)

+

Data are resting membrane currents in 25 mM K at a holding potential of -100mV divided by
the cell membrane capacitance
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Effects of RGS3s and RGS4 on acute desensitization of GIRK currents
In the absence of RGS co-expression, GIRK currents modestly
desensitize during the short 15 s agonist application period (<10% of their
amplitude). Co-expression of RGS4 causes a significant increase in the rate of
‘acute’ desensitization which is attributable to the accelerated rate of signal
termination during sustained receptor activation (Chuang et al., 1998; Doupnik et
al., 1997). Shown in Fig. 4.4, comparisons of the extent of acute desensitization
with RGS3s versus RGS4 expression during the 15 s agonist application period
indicate equivalent effects on both IK,5-HT and IK,ACh. These findings are consistent
with the rate of acute GIRK current desensitization being closely correlated with
Gα GTPase activity and best reflected in the GIRK deactivation rates (Chuang et
al., 1998; Leaney et al., 2004). As shown earlier for RGS3s and RGS4 (Figs. 4.2
and 4.3), both RGS proteins accelerate GIRK deactivation rates to a similar
degree.
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Figure 4.4. Acute GIRK current desensitization associated with different GPCRRGS coupling conditions. (A) Comparative effects of RGS3s (red trace) and
RGS4 (blue trace) on acute desensitization of 5-HT1A receptor-activated GIRK
currents without exogenous RGS expression (control, black trace). Peak
amplitudes of the superimposed recordings were normalized for kinetic
comparisons. Right panel: the percent desensitization was quantified by
measuring the percent decline in the peak GIRK current amplitude measured at
the end of the 15 s application period, as denoted by the application ‘‘window’’
(dotted box in left panel). Data are the mean±SE where * indicates a P<0.05 for
comparisons between the control and RGS groups. (B) Comparative effects of
RGS3s (red trace) and RGS4 (blue trace) on acute desensitization of muscarinic
m2 receptor-activated GIRK currents without exogenous RGS expression
(control, black trace). Right panel: quantification of acute GIRK desensitization
was determined as described in (A).
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RGS3s

RGS4

DISCUSSION

The goal of this study was to evaluate the modulatory effects of a recently
identified ‘short’ RGS3 isoform on neuronal GIRK channels activated by different
GPCRs in a mammalian cell expression system (CHO-K1 cells). The RGS3s
mRNA transcript is abundant in mouse brain and heart (Reif and Cyster, 2000)
and therefore may modulate GPCR regulation of neuronal and cardiac cell
excitability. The effects of RGS3s were assessed in comparison to the closely
related and previously studied RGS4 protein (Doupnik et al., 1997; Zhang et al.,
2002) that is co-expressed with RGS3 in individual neurons and atrial
cardiomyocytes (Doupnik et al., 2004; Doupnik et al., 2001). The major finding of
my experiments is that RGS3s modulates GIRK channels in a GPCR-dependent
manner, whereas RGS4 modulated GIRK channels similarly for both of the
GPCRs studied. RGS3s significantly reduced GIRK current amplitudes with m2
receptor coupling and shifted the steady-state agonist dose-response relations,
whereas RGS4 affected m2 receptor-activated GIRK currents similar to that
observed with 5-HT1A receptors. These results may indicate RGS3s has distinct
interactions with muscarinic m2 versus 5-HT1A receptor complexes, whereas
RGS4 interacts similarly with both GPCR-GIRK channel complexes. There are
several possible RGS-affected cellular processes that may contribute toward the
modulatory differences that we have identified and are briefly discussed below.

60

GTPase accelerating activity of RGS proteins
The GTPase accelerating activity of RGS proteins is mediated by direct
interactions between the RGS domain and the Gα subunit (Ross and Wilkie,
2000), and differences in RGS modulation of GIRK channels can reflect
differences in RGS-Gα subunit selectivity (Doupnik et al., 1997; Zhang et al.,
2002). Although RGS3 and RGS4 both interact with Gαi/o and Gαq/11 subunits,
RGS3 displays a higher affinity for Gα11 versus Gαi3 (Dulin et al., 1999; Neill et
al., 1997) and RGS4 shows preferential interactions with Gαi/o subunits versus
Gαq (Berman et al., 1996a). So for the Gαi-coupled receptors examined in my
CHO-K1 experiments, these preferred RGS-Gα associations would generally
favor greater accelerated GIRK deactivation rates with RGS4 compared to
RGS3s. Yet to the contrary, these kinetic differences were not observed and in
fact RGS3s accelerated the GIRK deactivation rate somewhat greater than
RGS4. Thus differences in RGS3s versus RGS4 affinity for Gαi subunits are not
apparent in the accelerated GIRK channel gating properties that reflect RGSenhanced GTPase accelerating activity and seem unlikely to explain my findings.

RGS membrane association
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Several members of the R4 subfamily, including RGS4, enhance
membrane binding through a mechanism requiring their short N-terminal domain.
These RGS proteins (RGS2, RGS4, RGS5, RGS8, RGS16, RGS18) possess Nterminal palmitoylated cysteine residues and a conserved basic amphipathic αhelix that confers membrane association and orientation that enhances their
GTPase activating activity (Bernstein et al., 2000; Chen et al., 1999; Heximer et
al., 2001; Saitoh et al., 2001; Tu et al., 2001). The RGS4 N-terminus also
contains a ubiquitin degradation signal (Davydov and Varshavsky, 2000). Yet for
both RGS4 and RGS8, deleting the N-terminal domain does not significantly
affect RGS-accelerated activation and deactivation kinetics for GPCR-activated
GIRK channels expressed in Xenopus oocytes, indicating RGS domain-Gα
interactions are sufficient for these kinetic effects (Inanobe et al., 2001; Saitoh et
al., 2001). However, deleting the RGS8 N-terminus does reduce acute
desensitization during dopamine D2 receptor GIRK channel activation (Saitoh et
al., 2001) which is attributable to RGS-enhanced GTPase activity (Chuang et al.,
1998). Remarkably, a ‘short’ RGS8 splice variant (RGS8s) differing only by the
first 7-9 N-terminal residues shows diminished effects on GIRK activation and
deactivation kinetics and altered selectivity for Gq-coupled receptor signaling
(Saitoh et al., 2002). Furthermore, overexpression of the RGS8 N-terminal
domain (1-5 a.a.) in rat sympathetic neurons dramatically accelerates α2adrenergic receptor activation of heterologously expressed GIRK channels,
supporting an important role of the RGS8 N-terminus in facilitating receptor-GIRK
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channel coupling (Jeong and Ikeda, 2001). In my comparison of RGS3s and
RGS4 on GIRK kinetics reported here, despite their divergent N-terminal
sequences, both displayed similar accelerating effects on GIRK activation and
deactivation kinetics and equivalent effects on acute desensitization of receptoractivated GIRK currents. Therefore, apparently, differences in RGS3s and RGS4
N-terminal domains do not confer obvious kinetic differences in receptordependent GIRK channel gating, despite their differential effects on receptordependent steady-state gating properties.

RGS-mediated translocation of GPCRs
RGS4 is predominantly a cytosolic protein recruited to membranes by
interactions with G protein subunits (Druey et al., 1998). RGS-specific
translocation from the cytosol to the plasma membrane involves direct
interactions with the GPCR complex and is determined in part by the relative
affinity of the RGS-Gα subunit interaction (Masuho et al., 2004; Roy et al., 2003).
It remains unclear whether cytosolic RGS proteins can incorporate into mature
GPCR-GIRK channel complexes already located at the plasma membrane, or
whether they co-assemble

within

the GPCR-GIRK

channel complexes

synthesized and assembled within the endoplasmic reticulum and Golgi
apparatus (Lavine et al., 2002). Current evidence, however, clearly indicate
RGS4 facilitates trafficking and recruitment of G proteins (Chuang et al., 1998)
and m2 receptore Gαi2 complexes (Roy et al., 2003) from intracellular pools to
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the plasma membrane, and thereby increases the density of functional receptors
at the plasma membrane. For RGS8, deletion of the N-terminal domain (∆NRGS8) prevents G protein-induced subcellular translocation of ∆N-RGS8 to the
plasma membrane (Saitoh et al., 2001). Similarly, translocation of the original
RGS3 isoform from the cytosol to the plasma membrane also occurs but in an
agonist- and Ca2+-dependent manner (Dulin et al., 1999). The Ca2+- dependent
translocation of RGS3 was recently shown to be mediated by Ca2+ binding to an
EF-hand motif located in the N-terminus of RGS3, which is not present in the
shorter N-terminus of RGS3s (Tosetti et al., 2003). Together, these findings
suggest RGS4 may translocate m2 receptor/Gαi complexes to the plasma
membrane more effectively than RGS3s, due either to a lower RGS3s-Gαi
affinity and/or a reduced efficacy of the RGS3s N-terminal domain in the
translocation process. The consequence in either case would be a lower cell
surface concentration of receptors with RGS3s expression, which is consistent
with the reduced GIRK current responses and rightward shift in the ACh dose
response curve observed with RGS3s expression. What is puzzling with this
working hypothesis is why the RGS3s effect on steady-state receptor-dependent
GIRK activation properties are more prominent for m2 receptors and less so for
5-HT1A receptor complexes.

Direct RGS-GPCR interactions
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Similar to my observations reported here, different R4 RGS proteins
exhibit GPCR-selective modulation of Gq/11-coupled (Wang et al., 2002; Xu et
al., 1999) and other Gi/o-coupled signaling pathways (Ghavami et al., 2004).
Moreover, the N-terminal domains of RGS3, RGS4, and RGS8 have been shown
to affect the selective regulation among Gq/11-coupled receptors (Chatterjee et
al., 1997; Saitoh et al., 2002; Zeng et al., 1998). Recently, the N-terminus of
RGS2 was shown to have direct and selective interactions with the 3rd
intracellular (i3) loop of Gq/11-coupled muscarinic receptors in vitro (Bernstein et
al., 2004). Full-length RGS4 also interacts with the i3 loop of Gq/11-coupled
muscarinic m1 and m5 receptors, but similar to RGS2, does not interact with the
i3 loops of Gi/o-coupled m2 or m4 receptors (Bernstein et al., 2004). Thus direct
interaction of RGS4 with the m2 receptor remains to be resolved, yet apparently
does not involve interactions with the i3 loop. Given the divergent nature of the
RGS3s N-terminal domain compared to RGS4, differential interactions of the
RGS3s N-terminus with GPCRs seems plausible and could thereby affect the
efficacy of receptor translocation to the plasma membrane and/or G protein
activation in a GPCR-selective manner. The intrinsic G protein coupling
properties of different GPCRs may also impact RGS interactions within the
signaling complex. In the absence of overexpressed RGS proteins in CHO-K1
cells, GIRK channels activated by m2 receptors and 5-HT1A receptors displayed
significantly different agonist potencies with 5-HT being ~30-fold more potent
than Ach (cf. Fig. 3.1). Differences in receptor expression, cell surface density,
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and receptor translocation (i.e. 5-HT1A>m2 receptors) are all possible
contributors to this observed difference as discussed above. The 5-HT1A
receptor-coupled GIRK channels also displayed a PTX-insensitive component
that may reflect promiscuous G protein coupling or coupling of residual Gαi
subunits (not ADP-ribosylated) due to a higher coupling affinity. Reconstitution
experiments comparing GPCR-Gαi binding affinities recently found agonistbound 5-HT1A receptors to have a 12-fold higher affinity for Gαi1(GDP)βγ
compared to agonist-bound m2 receptors (Slessareva et al., 2003), indicating
agonist-activated 5-HT1A receptors have an intrinsically higher efficacy for
Gαi(GDP)βγ coupling compared to muscarinic m2 receptors. GPCR differences
in intrinsic G protein coupling (i.e. precoupling) and the influence of associated
RGS proteins are important considerations for future mechanistic investigations
(Shea and Linderman, 1997). From our results described here, RGS3s and
RGS4 could produce equivalent modulatory effects on 5-HT1A receptor-coupled
GIRK channels due to a higher degree of G protein precoupling compared to m2
receptors (Zhang et al., 2002).
In summary, I compared the functional properties of the RGS3s isoform
and RGS4 due to their expression in brain and heart (Kehrl et al., 2002; Reif and
Cyster, 2000) and in native GIRK-expressing neurons and atrial myocytes
(Doupnik et al., 2004; Doupnik et al., 2001). The GPCR dependent effects of
RGS3s observed on neuronal GIRK channel function raise new questions
regarding RGS-dependent modulation of GPCR-GIRK channel complexes.
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To test if there is a selective interection among RGS-GIRK-GPCR
complexes I next generated several RGS chimeras and deletion constructs,
epitope tagged them, and by co-immunoprecipitation detected the possible
interactions.
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CHAPTER 5

RGS4 DIRECTLY ASSOCIATES WITH MULTIPLE GPCR-KIR3
CHANNEL SIGNALING COMPLEXES

INTRODUCTION

RGS4, a member of the “Regulators of G protein Signaling” gene family
(Hollinger and Hepler, 2002; Ross and Wilkie, 2000), is abundantly expressed in
the mammalian brain and peripheral nervous system (Druey et al., 1996; Gold et
al., 1997; Koelle and Horvitz, 1996). Functionally, RGS4 augments the GTPase
activity of Gi/o and Gq/11 proteins and accelerates the termination of G proteincoupled receptor (GPCR) signaling (Berman et al., 1996b; Hepler et al., 1997;
Mukhopadhyay and Ross, 1999; Watson et al., 1996). Genetic linkage and
association analysis has identified the human RGS4 gene as a major
susceptibility locus (chromosome 1q21-q22) for schizophrenia (Brzustowicz et
al., 2000; Chowdari et al., 2002), where gene profiling studies have shown RGS4
expression to be the most significantly reduced gene in the prefrontal cortex of
schizophrenic subjects (Mirnics et al., 2001). These findings, together with the
potential role of RGS4 in regulating several neurotransmitter systems known to
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affect symptoms of schizophrenia (hallucinations, delusions, and depression),
implicate RGS4 in the etiology of schizophrenia (Harrison and Weinberger,
2005). Decreased RGS4 levels are also reported to correlate with the reduced
cholinergic signaling found in Alzheimer’s disease (Muma et al., 2003).
Aside from its potential role in neurological disease and disorders, RGS4
is a highly regulated modulator that provides adaptive capabilities during various
levels of cell signaling (Chidiac and Roy, 2003). At the transcriptional level, brain
RGS4 mRNA levels are dynamically regulated by neurotransmitter activation of
different GPCRs (Geurts et al., 2002; Geurts et al., 2003; Taymans et al., 2003),
several drugs of abuse (cocaine, morphine, and amphetamines) (Bishop et al.,
2002; Garnier et al., 2003; Gold et al., 2003), stress and glucocorticoids (Ni et al.,
1999), and electroconvulsive seizures (Gold et al., 2002). At the posttranslational level, RGS4 protein is rapidly degraded via the ubiquitin-dependent
N-end rule pathway, a process initiated by arginylation of Cys2 by arginyltransferases (Davydov and Varshavsky, 2000; Lee et al., 2005) and tightly
coupled to the oxidative environment (Hu et al., 2005). Together these findings
illustrate the multiple layers of regulation that determine the RGS4 protein
concentration level that modulates Gi/o and Gq/11 signaling in the brain.
One of the key effectors for Gi/o and Gq/11–coupled receptors that
modulates neuronal excitability is the G protein-gated inwardly rectifying K+
(Kir3/GIRK) channel (Stanfield et al., 2002; Yamada et al., 1998). Kir3 channels
in hippocampal neurons are localized to dendrites, dendritic spines, and the cell
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soma (Drake et al., 1997) and thus well positioned for suppressing excitation
following activation by pertussis toxin (PTX)-sensitive Gi/o-coupled receptors as
evidenced in seizure-prone Kir3.2 knockout mice (Luscher et al., 1997; Signorini
et al., 1997). In contrast to activation by Gi/o–coupled receptors, Kir3 channels
are inhibited by PTX-insensitive Gq/11-coupled receptor signaling causing
enhanced neuronal excitability (Nakajima et al., 1988). Kir3 channels can form
stable macromolecular signaling complexes containing Gi/o– or Gs-coupled
receptors (Lavine et al., 2002), heterotrimeric G proteins (Clancy et al., 2005;
Huang et al., 1995; Ivanina et al., 2004; Krapivinsky et al., 1995b), and multiple
kinases and phosphatases (Nikolov and Ivanova-Nikolova, 2004). Since RGS4
significantly accelerates both the activation and deactivation time course for Gi/ocoupled receptor-activated Kir3 channel currents without compromising current
amplitude (Doupnik et al., 1997), it has been questioned whether RGS4 directly
binds to GPCR-Kir3 channel complexes as a means of efficacious modulation
and targeting specificity (Zhang et al., 2002). It is shown here that RGS4 directly
interacts with several GPCR-Kir3 channel complexes comprised of either Gi/o or
Gq/11-coupled receptors expressed in CHO-K1 cells. RGS4 coupling is mediated
through interactions with the GPCR versus the Kir3 channel, and displays
specificity since a closely related RGS homolog (RGS3s) (Jaen and Doupnik,
2005; Reif and Cyster, 2000) does not interact with any of the GPCR-Kir3
channel complexes tested.
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RESULTS

RGS4 and RGS3s protein expression in CHO-K1 cells.
To determine whether RGS4 or RGS3s directly associate with GPCR-Kir3
channel complexes I co-expressed N-terminal HA-tagged m2 receptors, Cterminal MYC-tagged Kir3.1/Kir3.2a channels, with and without C-terminal FLAGtagged RGS3s or RGS4, in CHO-K1 cells. The HA-m2 receptor or the Kir3.1MYC subunit was then immunoprecipitated and probed for co-precipitating
proteins by western blot analysis. Initial western blot analysis of cell lysates
reaffirmed previous findings (Krumins et al., 2004) indicating RGS4 protein levels
are low and often undetectable, and significantly less than RGS3s (Figure 5.1A).
This has been attributed to the rapid degradation of RGS4 via the
ubiquitin/proteasome-dependent N-end rule pathway initiated by arginylation of
RGS4 at Cys2 (Davydov and Varshavsky, 2000; Lee et al., 2005). RGS3s
notably lacks this N-terminal cysteine residue. I therefore also compared protein
levels of the degradation-resistant RGS4(C2V) mutant (Davydov and Varshavsky,
2000). As shown in Figure 5.1B, the level of RGS4(C2V) protein in the cell lysate
was significantly greater than wildtype RGS4 and more comparable to the protein
levels observed with RGS3s expression. Both RGS3s-FLAG (23.5 kDa) and
RGS4(C2V)-FLAG (24.25 kDa) migrated near their calculated molecular weights
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and were often accompanied by a slightly smaller band of lower intensity that
may represent some degree of proteolysis or alternative translation initiation start
site (Krumins et al., 2004). Given the similar and stable expression levels of
RGS3s and RGS4(C2V), RGS4(C2V) was routinely used for immunodetection and
for comparisons with RGS3s.
Functional tests of co-expressed HA-tagged m2 receptors with Kir3.1MYC/Kir3.2a channels revealed ACh-elicited inwardly rectifying K+ currents were
indistinguishable from those produced by their untagged counterparts reported
previously (Jaen and Doupnik, 2005). Comparative analysis of the modulatory
effects of FLAG-tagged RGS3s, RGS4, and RGS4(C2V) on the kinetics of IK,ACh
activation and deactivation indicated all three RGS proteins accelerated Kir3
channel gating properties to similar extents (Figure 5.1D,E). This was somewhat
unexpected given the large difference in protein expression between RGS4 and
RGS4(C2V), and suggests RGS4 protein levels (significantly lower than RGS3s
and RGS4(C2V)) are saturating with regards to functional Kir3 channel
modulation. Also consistent with my previous study (Jaen and Doupnik, 2005),
RGS3s-FLAG caused a significant rightward shift in the ACh dose response
relation (Figure 5.1F) and reduced peak IK,ACh amplitudes by ~50% (data not
shown).
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Figure 5.1. RGS3s, RGS4, and the degradation-resistant RGS4(C2V) mutant are
differentially expressed in CHO-K1 cells, yet similarly affect muscarinic m2
receptor-activated Kir3 channel current kinetics. (A & B) Western blot analysis of
C-terminal FLAG-tagged RGS3s, RGS4, and RGS4(C2V) protein levels in
transfected CHO-K1 cell lysates. Cells for each RGS group were co-transfected
with the HA-tagged m2 receptor, C-terminal MYC-tagged Kir3.1 subunit, and the
Kir3.2a subunit (see Methods for details). Sample lanes were each loaded with
20 µg of total protein. (C) Whole-cell recordings of ACh-activated Kir3 channel
currents from CHO-K1 cells expressing either no RGS (black traces), RGS3sFLAG (red trace), RGS4-FLAG (blue trace), or RGS4(C2V)-FLAG (green trace).
The peak currents have been normalized to compare the RGS-dependent effects
on Kir3 channel gating kinetics during and after a 15 s application of 1 µM ACh.
The current deflections before and during ACh application are responses to
voltage ramps (-100 mV to +50 mV) used to monitor inward rectification. The
holding membrane potential was -100 mV in all cases. (D & E) RGS3s-FLAG
(red), RGS4-FLAG (blue), and RGS4(C2V)-FLAG (green) similarly accelerate the
activation and deactivation time course for m2 receptor-activated Kir3 channel
currents. Single exponential fits to the activation and deactivation time course
were performed to derive the time constants, τact and τdeact, respectively. The
ACh concentration-dependence of τact is shown for each RGS examined (panel
F). The τdeact values are following the rapid washout of 1 µM ACh. Values are the
mean±SEM (n=7-9). (F) ACh-dose response relations for ACh-evoked Kir3
channel currents expressing either no RGS (black symbols), RGS3s-FLAG (red
symbols), RGS4-FLAG (blue symbols), or RGS4(C2V)-FLAG (green symbols).
Mean values were fit with a Hill function (solid curves) to compare EC50 values
for each condition.
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Differential RGS interaction with m2 receptor-Kir3 channel complexes.
HA-tagged m2 receptor was immunoprecipitated and probed for coprecipitating Kir3.1-MYC and RGS-FLAG by western blot analysis. Shown in
Figure 5.2, Kir3.1-MYC readily co-precipitated with the muscarinic m2 receptor
demonstrating the presence of stable m2 receptor-Kir3 channel complexes
similar to that reported for other GPCRs (Lavine et al., 2002). Interestingly
though, while RGS4(C2V) readily co-precipitated with the m2 receptor-Kir3
channel complex, RGS3s did not. The apparent molecular weights of the
immunoprecipitated proteins were consistent with predicted and previously
reported values. The immunoprecipitated HA-m2 receptor migrated as two major
bands, one molecular weight band that closely corresponded to the calculated
molecular weight (52.81 kDa) and a higher band (70-75 kDa) that corresponds to
glycosylated receptors (van Koppen and Nathanson, 1990). The co-precipitated
Kir3.1-MYC subunit also migrated close to its calculated molecular weight (57.77
kDa).
I next questioned whether the availability Gi proteins might influence the
coupling of RGS3s and RGS4 to m2 receptor-Kir3 channel complexes given
potential limiting levels of endogenous Gi proteins present within the CHO-K1
cells. To test this, I examined the effects of co-expressing the Gαi2 subunit on
RGS co-precipitation with the m2 receptor-Kir3 channel complex. As shown in
Figure 5.3, Gαi2 expression appeared to slightly enhance wildtype RGS4 protein
levels and RGS4 was now detected as a co-precipitating protein with the m2
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receptor-Kir3 channel complex. Yet similar to the previous experiments without
Gαi2 expression, RGS3s again did not co-precipitate with the complex and
RGS4(C2V) was readily detected (Figure 5.3). Levels of RGS3s and RGS4(C2V)
protein in the cell lysates were roughly equivalent, indicating the lack of RGS3s
association with the complex was not attributable to differences in protein
availability. These experiments clearly demonstrate that RGS4 and RGS4(C2V)
can form a stable interaction with m2 receptor-Kir3 channel complexes and that
the closely related RGS3s isoform does not interact with the same complex.
The m2 receptor-Kir3 channel complex could also be immunopreciptated
via the Kir3.1-MYC channel subunit, where the co-precipitating m2 receptor was
then detected by western blot (data not shown). Yet in this configuration, coexpression of Gαi2 blocked immunoprecipitation of Kir3.1-MYC. I speculate that
immunoprecipitation via the cytosolic C-terminal Kir3.1-MYC epitope may be
perturbed by cytosolic G protein interactions that map to the Kir3 C-terminus
(Clancy et al., 2005).

76

Figure 5.2. Selective association of RGS4 with muscarinic m2 receptor-Kir3
channel complexes. HA-muscarinic m2 receptors were immunopreciptated from
CHO-K1 cells co-expressing Kir3.1- MYC/Kir3.2a channels and either no RGS,
RGS3s-FLAG, or RGS4(C2V)-FLAG. Coprecipitating Kir3.1-MYC and RGS-FLAG
proteins were then probed by western blot analysis. Western blot of the level of
RGS-FLAG protein present within each of the cell lysates is shown in the lower
panel. Note that lane one (sham), which is a negative control, from CHO-K1 cells
transfected only with empty vector shows no unspecific binding of proteins in the
cell lysate to the agarose beads as well as any detection of coimmunoprecipitation. However, in the cell lysate, FLAG antibody shows some
unspecific binding to proteins that are present in all conditions even those without
RGS-FLAG protein expressed; those proteins have higher molecular weight than
the RGS-FLAG proteins. Nevertheless, looking at the appropriate molecular
weight between 20-25 kDa, specific RGS-FLAG detection from the cell lysates
can be observed only in the conditions that were transfected with RGS-FLAG
proteins.
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Figure 5.3. Effects of Gαi2 co-expression on RGS coupling to muscarinic m2
receptor-Kir3 channel complexes. A Gαi2 expression vector (the PTX-insensitive
Gαi2(C352G) mutant) was included in the CHO-K1 cell transfections as described
in figure 5.2. Note both RGS4 and RGS4(C2V) coprecipitate with the muscarinic
m2 receptor-Kir3 channel complex, whereas RGS3s does not.

79

80

Structural determinants of RGS4 binding to m2 receptor-Gα
αi2-Kir3 channel
complexes.
RGS3s and RGS4 share a high degree of sequence homology within their
conserved RGS domain (indeed they are nearest neighbors at 76% similarity),
yet have important differences in their N-terminal sequences (Figure 5.4A). The
N-terminal domain of RGS4 (aa 1-57) contains two palmitoylation sites (Cys2,
Cys12) (Srinivasa et al., 1998) and an amphipathic alpha-helix (a.a. 1-33)
(Bernstein et al., 2000; Tu et al., 1999; Tu et al., 2001) that are both highly
conserved among two other R4 RGS proteins, RGS5 and RGS16 (Chen et al.,
1999; Druey et al., 1999). The amphipathic alpha-helix of RGS4 is both
necessary and sufficient for membrane association (Bernstein et al., 2000;
Srinivasa et al., 1998) and is conserved in the RGS3s N-terminus (Figure 5.4A).
Yet the RGS3s N-terminus lacks the two palmitoylation sites (Cys2, Cys12) that
help target RGS16 (and presumably RGS4 and RGS5) to cholesterol-rich
membrane lipid rafts (Hiol et al., 2003) and enhances RGS GAP activity
(Bernstein et al., 2000; Srinivasa et al., 1998; Tu et al., 1999; Tu et al., 2001).
My initial hypothesis was that the RGS4 N-terminal domain was both
necessary and sufficient for association of RGS4 with m2 receptor-Gαi2-Kir3
channel complexes. To test this hypothesis, RGS4 deletion mutants and
RGS3s/RGS4 chimeras (all FLAG-tagged at the C-terminus) were individually
co-expressed along with the HA-m2 receptor, the Gαi2 subunit, and Kir3.1MYC/Kir3.2a

channels

(Figure

5.4B).
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The

HA-m2

receptor

was

then

immunoprecipitated and co-precipitating RGS proteins probed by western blot. In
support of my hypothesis, deleting the N-terminal domain of RGS4, RGS4(58205)-FLAG,

resulted in the loss of association with the m2 receptor-Kir3 channel

complex (Figure 5.4C) as expected with a loss of membrane association
(Srinivasa et al., 1998). Yet interestingly, substituting the RGS3s N-terminal
domain (a.a. 1-62) in place of the RGS4 N-terminal domain (R3s-R4-FLAG
chimera) also resulted in the complete loss of association with the m2 receptorKir3 channel complex (Figure 5.4C) suggesting palmitoylation of RGS4 Cys2 and
Cys12 may also be necessary. Together these results clearly demonstrate that
the RGS4 N-terminal domain is necessary for coupling to the signaling complex.
Surprisingly, however, substituting the RGS4 N-terminal domain (with or
without the C2V mutation) in place of the RGS3s N-terminal domain (R4-R3sFLAG chimera or R4(C2V)-R3s-FLAG chimera) conferred only very weak
interactions with the m2 receptor-Kir3 channel complex, significantly less than
RGS4(C2V) (Figure 5.4C). Thus the RGS4 N-terminal domain is clearly necessary
for association with the m2 receptor-Kir3 channel complex, however the
remaining RGS domain and/or C-terminus of RGS4 is also necessary for efficient
high-affinity coupling. Note that the expression of these various RGS constructs
had no effect on the level of m2 receptor-Kir3 channel coupling (Figure 5.4C),
indicating assembly of m2 receptor-Kir3 channel complexes is not affected by
RGS association.
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Figure 5.4. Structural determinants of RGS4 association with muscarinic m2
receptor-Kir3 channel complexes. (A) Amino acid sequence alignment of the
mouse RGS3 ‘short’ isoform and rat RGS4. Asterisks denote sites of sequence
identity and green residues denote the highly conserved RGS domain. The Nterminal amphipathic alpha helical domains are boxed and the conserved basic
residues highlighted in red, and the palmitoylated RGS4 C2, C12 residues
highlighted in orange. The arrowhead denotes the site for RGS deletions and
junction site for RGS chimeras. (B) Schematic diagram illustrating C-terminal
FLAG-tagged RGS proteins constructed and tested for co-precipitation with
muscarinic m2 receptor-Kir3 channel complexes. RGS4 regions are in blue,
RGS3s regions are in red. (C) The RGS4 N-terminal domain (a.a. 1-57) is
necessary for RGS association with muscarinic m2 receptor-Kir3 channel
complexes. Six different RGS-FLAG constructs were individually coexpressed
with HA-muscarinic m2 receptors, the Gαi2(C352G) subunit, and Kir3.1MYC/Kir3.2a channels in CHO-K1 cells. The HA-m2 receptor was then
immunoprecipitated and coprecipitating Kir3.1-MYC and RGS-FLAG proteins
detected by western blot. RGS-FLAG present in the cell lysates are shown in the
lower blot. Faint bands for RGS4(58-205)-FLAG (lane 2), the R4-R3s-FLAG (lane
5), and R4(C2V)-R3s-FLAG chimera (lane 6) could be detected, yet none of the
RGS constructs matched the level of coupling displayed by RGS4(C2V)-FLAG.
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RGS4(C2V) associates with multiple GPCR-Kir3 channel complexes
Kir3 channels are functionally coupled to a variety of Gi/o-coupled
receptors in the nervous system and heart (Stanfield et al., 2002; Yamada et al.,
1998). To determine whether RGS3s and RGS4 selectively associate with
different Gi/o-coupled receptors known to activate native Kir3 channels, I
examined RGS and Kir3 channel co-precipitation with several different HAtagged GPCRs (serotonin 1A, adenosine A1, dopamine D2L, and LPA1
receptors) co-expressed with either Gαi2 or GαoA. With Gαi2 expression, each
GPCR tested (serotonin 1A, adenosine A1, and LPA1 receptors) co-precipitated
Kir3.1-MYC/Kir3.2a channels (Figure 5.5 and Figure 5.6) and behaved just as the
muscarinic m2 receptor (cf, Figure 5.3). Moreover, each GPCR-Kir3 channel
complex demonstrated the same selectivity in associating with RGS4(C2V) but
not RGS3s. Wildtype RGS4 coupling was not readily detectable as RGS4
expression levels were significantly less than both RGS3s and RGS4(C2V).
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Figure 5.5. RGS4(C2V) associates with multiple Gi-coupled receptor-Kir3 channel
complexes. Three different HA-tagged GPCRs, the adenosine A1 receptor (3HAA1R), the serotonin 1A receptor (HA-5-HT1AR), and the lysophosphatidic acid 1
receptor (HA-LPA1R), were expressed in CHO-K1 cells with Kir3.1-MYC/Kir3.2a
channels, the Gαi2(C352G) subunit, and either no RGS, RGS3s-FLAG, RGS4FLAG,

or

RGS4(C2V)-FLAG.

Each

HA-tagged

GPCR

was

then

immunoprecipitated (IP) and co-precipitating (Co-IP) Kir3.1-MYC and RGS-FLAG
proteins detected by western blot (WB). Kir3.1-MYC and RGS4(C2V)-FLAG coprecipitated with each HA-GPCR.
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Similarly with GαoA expression, each GPCR tested (serotonin 1A,
adenosine A1, dopamine D2L, and LPA1 receptor) co-precipitated Kir3.1MYC/Kir3.2a channels and RGS4(C2V), but not RGS3s (Figure 5.6). Thus RGS3s
does not directly interact with a variety of Gi/o-coupled receptors, whereas
RGS4(C2V) coupling is rather promiscuous.
It is worth noting that the immunoprecipitation levels of the different HAtagged GPCR proteins varied considerably, with m2 receptors and dopamine
D2L receptors being markedly less than serotonin 1A, adenosine A1, or LPA1
receptors (Figure 5.6). The underlying cause for these differences are not clear,
and was not attributable to either the N-terminal HA tag (1X-HA versus 3X-HA) or
the presence of the signal sequence. The differences apparently reflect distinct
coding region differences that affect GPCR protein expression levels. The level
of

co-precipitating

RGS4(C2V)

did

not

correlate

with

the

level

of

immunoprecipitated HA-GPCR, being somewhat constant for each expression
condition and indicates the fraction of associated RGS4(C2V) differed for each
GPCR.
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Figure 5.6. RGS4(C2V) associates with multiple Go-coupled receptor-Kir3
channel complexes. Effects of GoA subunit expression on RGS coupling to
different GPCR-Kir3 channel complexes. Five different HA-tagged GPCRs, the
muscarinic m2 receptor (HA-m2R), the serotonin 1A receptor (HA-5-HT1AR), the
lysophosphatidic acid 1 receptor (HA-PA1R), the adenosine A1 receptor (3HAA1R), and the dopamine D2L (3HA-D2LR), were expressed in CHO-K1 cells with
Kir3.1-MYC/Kir3.2a channels, the GαoA(C351G) subunit, and either RGS4(C2V)FLAG (left panel) or RGS3s-FLAG (right panel). Kir3.1-MYC and RGS4(C2V)FLAG co-precipitated with each HA-GPCR, whereas RGS3s-FLAG did not
couple to any of the GPCR-Kir3 channel complexes.
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Since both RGS3 and RGS4 are also effective GAPs for Gαq (Hepler et
al., 1997; Scheschonka et al., 2000), I also tested whether RGS3s might
associate with a GPCR known to couple selectively to Gαq subunits, namely the
muscarinic m1 receptor. For these experiments I co-expressed Gαq and Kir3.1MYC/Kir3.2a channels, and tested in parallel three additional GPCRs that display
varying degrees of Gq coupling for comparison (LPA1, serotonin 1A, and m2
receptor). Interestingly, Kir3.1-MYC/Kir3.2a channels co-precipitated with the
muscarinic m1 receptor indicating Gq-coupled receptors can also form stable
complexes with Kir3 channels (Figure 5.7). As observed with the Gi/o-coupled
receptors, RGS3s again failed to couple to the m1 receptor-Kir3 channel complex
(or any of the other GPCR-Gαq-Kir3 channel complexes) whereas RGS4(C2V)
directly interacted with the m1 receptor-Kir3 channel complex (Figure 5.7). Thus
despite the functional effects of RGS3s on Kir3 channel gating kinetics (cf. Figure
5.1), RGS3s does not directly couple to any of the GPCR-Kir3 channel
complexes tested in my experiments.
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Figure 5.7. Kir3 channels and RGS4(C2V) co-assemble with Gq-coupled
receptors. Four different HA-tagged GPCRs, the muscarinic m2 receptor (HAm2R), the serotonin 1A receptor (HA-5-HT1AR), the lysophosphatidic acid 1
receptor (HA-LPA1R), the muscarinic m1 receptor (3HA-m1R), were expressed in
CHO-K1 cells with Kir3.1-MYC/Kir3.2a channels, the Gαq subunit, and either
RGS4(C2V)-FLAG (panel A) or RGS3s-FLAG (panel B). Each HA-tagged GPCR
was then immunoprecipitated (IP) and co-precipitating (Co-IP) Kir3.1-MYC and
RGS-FLAG proteins detected by western blot (WB). Kir3.1-MYC and RGS4(C2V)FLAG co-precipitated with each HA-GPCR (panel A), whereas RGS3s-FLAG did
not couple to any of the GPCR-Kir3 channel complexes (panel B). The RGSFLAG present in each of the cell lysates is shown in the lower blots.
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RGS4(C2V) couples to GPCRs independent of co-assembled Kir3 channels
The next question was whether RGS4(C2V) association with GPCR-Kir
channel complexes was mediated via specific GPCR interactions, by direct Kir3
channel interactions, or by interactions with both. To determine this I 1) coexpressed several GPCRs with RGS4(C2V) in the absence of Kir3 channel
expression, and 2) co-expressed RGS4(C2V) with Kir3.1-MYC/Kir3.2a channels in
the

absence

of

HA-GPCR

expression.

As

shown

in

Figure

5.8A,

immunoprecipitation of each HA-GPCR readily co-precipitated RGS4(C2V) in the
absence of Kir3 channel expression. Thus the GPCR alone is sufficient, and the
Kir3 channel not necessary for RGS4(C2V) coupling to GPCR complexes. Shown
in Figure 5.8B, in the absence of HA-GPCR expression, immunoprecipitation of
Kir3.1-MYC/Kir3.2a channels failed to co-precipitate RGS4(C2V).

94

Figure 5.8. RGS4(C2V) couples to GPCRs and not the Kir3 channel. (A) Six
different HA-tagged GPCRs (the muscarinic m2 receptor (HA-m2R), the
serotonin 1A receptor (HA-5-HT1AR), the lysophosphatidic acid 1 receptor (HALPA1R), the adenosine A1 receptor (3HA-A1R), the dopamine D2L (3HA-D2LR),
and the muscarinic m1 receptor (HAm1R), were expressed in CHO-K1 cells with
RGS4(C2V)-FLAG in the absence of Kir3.1-MYC/Kir3.2a channel expression.
Immunoprecipitation (IP) of each of the HA-GPCRs coprecipitated (Co-IP)
RGS4(C2V)-FLAG as determined by western blot (WB) analysis. (B) Coexpression of Kir3.1-MYC/Kir3.2a channels and RGS4(C2V)-FLAG in the absence
of HA-GPCR. Immunoprecipitation of Kir3.1-MYC failed to co-precipitate
RGS4(C2V)-FLAG as determined by western blot analysis.
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Functional impact of direct RGS4 coupling to GPCR-Kir3 channel
complexes
RGS3s, RGS4, and RGS4(C2V) each accelerated the activation and
deactivation gating kinetics of Kir3.1/Kir3.2 channels to equivalent extents in
CHO-K1 cells despite differences in their physical coupling to m2 receptor-Kir3
channel complexes (cf. Figure 5.1). Examination of the accelerating effects of
each of the N-terminal deletion constructs (RGS4(58-205) and RGS3s(63-192)) and
RGS chimeras (R3s-R4 chimera and R4-R3s chimera) on ACh-activated Kir3
channel currents recorded from CHO-K1 cells also failed to identify any
functional difference that might correlate with the differences in RGS precoupling
to the signaling complex (data not shown). I therefore questioned whether direct
RGS interaction with GPCR-Kir3 channel complexes in CHO-K1 cells was of no
functional benefit due to saturating levels of RGS protein expression and high
degree of RGS3s ‘collision coupling’.
To control and vary the expression levels of RGS3s and RGS4, the
Xenopus oocyte system was used because in that system protein expression
levels can be incrementally increased by titrating the amount of injected cRNA
(Zhang et al., 2002). Given the similar steady-state protein levels of RGS3sFLAG and the degradation-resistant RGS4(C2V)-FLAG mutant in CHO-K1 cells,
those were the RGS proteins used in the oocyte system. Concentrationdependent modulatory effects of these two RGS proteins on m2 receptoractivated Kir3.1/Kir3.2a channels expressed in Xenopus oocytes were examined.
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Shown in Figure 5.9, the amount of RGS3s-FLAG cRNA necessary to produce a
maximal acceleration in the Kir3 channel deactivation rate (10 ng/oocyte), was 30
times greater than the amount of RGS4(C2V)-FLAG cRNA necessary to produce
an equivalent effect (0.3 ng/oocyte). The derived EC50 values similarily indicate
there is a 30-fold greater potency for RGS4(C2V) (EC50, 0.12 ng cRNA/oocyte)
versus RGS3s (EC50, 3.3 ng cRNA/oocyte). These results reveal the primary
functional impact of direct RGS4 coupling is a greater potency in accelerating the
gating kinetics of receptor-activated Kir3 channels through targeted association.
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Figure 5.9. Differential potency of RGS3s and RGS4(C2V) in accelerating the
deactivation kinetics of muscarinic m2 receptor-activated Kir3 channel currents in
Xenopus oocytes. (A) ACh-activated Kir3 channel currents recorded from
oocytes expressing the muscarinic m2 receptor, Kir3.1/Kir3.2a channel subunits,
and either RGS3s-FLAG (red traces) or RGS4(C2V)-FLAG (green traces) at two
different expression levels (1 and 10 ng cRNA/oocyte). Inward Kir3 channel
currents were elicited by a 25 s application of 1 µM ACh, from a holding potential
of -80 mV. Current amplitudes have been normalized to illustrate kinetic
differences in the activation and deactivation time course. (B) Concentrationdependent effects of RGS3s-FLAG (red symbols) and RGS4(C2V)-FLAG on Kir3
channel deactivation kinetics. The deactivation time course following the rapid
removal of 1 µM ACh was fit with a single exponential function to derive
deactivation time constants. Separate groups of oocytes injected with increasing
amounts of cRNA (0.03-10 ng/oocyte) encoding RGS3s-FLAG (red symbols) or
RGS4(C2V)-FLAG (green symbols) were tested in parallel. Values represent the
mean±SEM (n=8) from two separate batches of oocytes. Mean time constant
values for RGS3s-FLAG (red symbols) and RGS4(C2V)-FLAG (green symbols)
were fit with a modified Hill function to derive the effective concentration of cRNA
(ng/oocyte) producing 50% of the maximal acceleration in current deactivation
(EC50).
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DISCUSSION

RGS4(C2V) precouples to multiple GPCRs
My findings reported here demonstrate a remarkable promiscuity in the
association of RGS4(C2V) with several Gi/o and Gq/11-coupled receptors that
assemble with Kir3 channels to form macromolecular signaling complexes.
Critical to this observation was the utilization of the degradation-resistant
RGS4(C2V) mutant that increased protein expression and enabled reliable
detection of RGS4(C2V) in my co-immunoprecipitation assays. RGS4(C2V)
demonstrated a strong interaction with each of the GPCRs tested, but did not
directly interact with the Kir3 channel, indicating selectivity in association with
different transmembrane proteins. A previous study had found recombinant GSTRGS4 fusion protein to interact in vitro with Kir3 channels expressed in HEK293
cells, suggesting a direct RGS4-Kir3 channel interaction (Fujita et al., 2000). In
light of my findings, the GST-RGS4 interactions may have been with endogenous
GPCRs co-assembled with the Kir3 channels expressed in HEK293 cells.
Alternatively, RGS4 may have interactions with Kir3 channels that are not
detected in our co-immunoprecipitation experiments, but more apparent using
the recombinant RGS4 protein. The association of RGS4(C2V) to multiple Gi/o
and Gq/11-coupled receptors independent of the Kir3 channel effector, suggests
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precoupled RGS4-GPCR complexes are likely to participate in the G-proteindependent modulation of several other known ion channel effectors regulating
neuronal excitability (e.g. Kir2 and Kir6 channels, KCNQ channels, TRP
channels, and voltage-gated Ca2+ channels).

Structural determinants of RGS4 coupling to GPCRs
RGS4 was recently found to directly interact with the third intracellular loop
(i3L) of muscarinic m1 and m5 receptors, but not the i3L of m2 receptors
(Bernstein et al., 2004). My experiments showing RGS4(C2V) co-precipitates with
muscarinic m1 receptors is therefore interpreted as a result, at least in part, of
direct protein-protein interactions between RGS4(C2V) and the m1 receptor. The
lack of RGS4 interactions with the i3L of m2 receptors (Bernstein et al., 2004)
suggests other m2 receptor domains may also participate in direct receptorRGS4 coupling, or alternatively the coupling could be mediated indirectly via
interactions with precoupled Gαi/o subunits or other proteins. Recent reports of
RGS4 co-precipitating with µ- or δ-opioid receptors from periaqueductal gray
membranes (Garzon et al., 2005) and involving direct interactions between
RGS4 and the C-terminal domains of µ- or δ-opioid receptors (Georgoussi et al.,
2005) suggests RGS4 may also directly bind to the C-terminal domain of other
GPCRs including the m2 receptor.
The structural determinants of RGS4 that mediate association with GPCRKir3 channel complexes support a critical role of the RGS4 N-terminal domain,
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since deleting the N-terminus and substituting the RGS3s N-terminus (R3s/R4
chimera) resulted in decoupling from the GPCR-Kir3 channel complex. Since the
RGS4 N-terminus confer membrane association (Srinivasa et al., 1998) and
contains two palmitoylation sites that are expected to facilitate targeting to
membrane lipid rafts (Hiol et al., 2003) where GPCRs (Papoucheva et al., 2004),
heterotrimeric G proteins (Moffett et al., 2000), and Kir3 channels localize
(Delling et al., 2002), there are apparent cooperative and selective interactions
involving the RGS4 N-terminus and the RGS4 RGS domain that together
mediate the high affinity coupling. My findings are consistent with the model
proposed by Wilkie and colleagues (Zeng et al., 1998), where the RGS4 Nterminus directly interacts with the GPCR and the RGS domain interacts with the
precoupled Gα subunit. Thus receptor-RGS4 association is expected to increase
the degree of precoupled receptor-G protein complexes. Recent fluorescence
resonance energy transfer (FRET) experiments

support a stable interaction

between RGS proteins (RGS7 and RGS8) and Gα subunits within an agonistreceptor-G-protein quaternary complex (Benians et al., 2005). Importantly,
however, these experiments did not detect FRET between RGS8 and the GPCR,
indicating the RGS-Gα FRET signals could be potentially derived via a collisioncoupled process. It will be important to extend our co-immunoprecipitation
experiments to RGS8 and other members of the RGS protein family to identify
RGS proteins that stably associate with different GPCRs, and identify those that
do not.
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Although I found no evidence for receptor-specific association of
RGS4(C2V), wildtype RGS4 coupling was low or not detectable for each of the
GPCRs tested. This may be in part due to the low RGS4 protein levels caused by
the rapid degradation of RGS4 via the N-end rule pathway (Davydov and
Varshavsky, 2000), or alternatively could reflect effects of Cys2 modifications on
coupling to GPCRs. The RGS4 Cys2 residue is the target of palmitoylation
(Srinivasa et al., 1998), arginylation (Davydov and Varshavsky, 2000),
nitrosylation (Hu et al., 2005), and oxidation (Hu et al., 2005), where the
RGS4(C2V) mutant would be insensitive to any negative effects of Cys2
modifications on GPCR coupling. Future studies exploring the role of the RGS4
Cys2 site and its modifications on the efficacy of specific GPCR coupling will be
needed to resolve this fascinating possibility.

Implications of RGS4 precoupling versus RGS3s collision-coupling
My initial electrophysiological measures of RGS3s- versus RGS4dependent modulation of Kir3 currents in CHO-K1 cells did not reveal any
functional advantage for precoupled RGS4 proteins versus uncoupled RGS3s.
Yet RGS dosage experiments in Xenopus oocytes clearly demonstrated that
RGS4(C2V) precoupling provides a 30-fold greater potency in Kir3 channel
modulation versus uncoupled RGS3s. These findings illustrate the high level of
RGS collision-coupling that occurs in the CHO-K1 expression experiments, a
likely result of the high protein expression levels produced in this commonly used
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mammalian expression system. Functional assays probing for RGS-GPCR
coupling specificity using similar assay systems are likely biased for ‘falsepositives’ due to the high degree of RGS collision-coupling and the generally low
selectivity of several RGS proteins towards Gi/o, Gq/11, and Gz subunits.
Experimental protocols implementing RGS dosage in live cell assays should help
resolve RGS selectivity in the modulation of specific GPCR signaling pathways.
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CHAPTER 6

CONCLUDING REMARKS

The original purpose of this study was to characterize the specific RGS
proteins that modulate endogenous neuronal GIRK channels. Initially I used CG
neurons, a native cell type that endogenously expresses GIRK channels. In order
to determine the endogenous RGS proteins that were likely to be involved in
GIRK channel modulation, a RGS expression profile was performed. This work
has shown that CG neurons can express at least 13 RGS genes. Comparison of
RGS gene expression profiles from different native cell types (i.e. CG neurons vs
cardiac myocytes) can give us an indication of which RGS proteins may be
physiologically important for each cell type.
It has been demonstrated that GIRK channels can form stable signaling
complexes with GPCRs (Lavine et al., 2002), and multiple RGS proteins are
expressed within single GIRK-expressing neurons and atrial myocytes (Doupnik
et al., 2004; Doupnik et al., 2001; Gold et al., 1997).
How are cells able to specifically activate a determined signaling
pathway?
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One way of signaling pathway specificity may come through selective
interaction of RGS proteins with various GPCR-effector signaling complexes.
To test this hypothesis I studied RGS3s and RGS4, two RGS’s whose
mRNA levels are transcriptionally regulated in the nervous system during
pathophysiologic conditions (Costigan et al., 2003).
My findings demonstrate a tight coupling between RGS4 and several
GPCRs that are central participants in normal and pathologically altered
neuromodulation. Interaction among the different GPCRs-GIRK-RGS proteins
seems to be very specific, since only RGS4 was able to co-immunoprecipitate
with the GPCR-GIRK channel signaling complexes and RGS3s was not (Figure
6.1).
My results highlight the importance that selective RGS-GPCR interactions
may have physiologically. The functional impact of RGS4(C2V) precoupled to the
GPCR-Kir3 channel complex was a 30-fold greater potency in the acceleration of
Kir3 channel gating kinetics, compared to the uncoupled (or collision coupled)
RGS3s. This disparity in potency observed between RGS4(C2V) and RGS3s is
probably due to the coupling of RGS4(C2V) to the GPCR-GIRK signaling
complex. Further experiments in the oocyte system using the different chimeras
and deletion constucts are needed to corroborate this hypothesis.
Given the multiple mechanisms affecting RGS4 protein levels, it will be
important to determine to what extent these changes in RGS4 concentration
affect coupling to different GPCR signaling pathways. Recently, a mutation in an
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RGS protein, RGS9-1 that is involved in the rhodopsin signaling complex has
been shown to be the cause of a disease (bradyopsia) in humans, a non-lethal
condition characterized by an inability to resolve rapidly changing visual scenes
(Nishiguchi et al., 2004).
In summary, my findings demonstrate that RGS4, a highly regulated
modulator and susceptibility gene for schizophrenia, is an integral component of
multiple

GPCR-Kir3

channel

complexes

affecting

a

wide

range

of

neurotransmitter-mediated events in the nervous system. Acquired or inherited
disruptions in RGS4-GPCR coupling may also be critical for a variety of
neurological disorders that may include schizophrenia, depression, epilepsy, and
drug addiction. Future experiments in native tissue are needed to detect the
location and identification of the distinct RGS proteins involved in the coupling to
the different GPCR-effector signaling complexes. Although my experiments have
been performed in an heterologous system, the interactions reported here may
be physiologically important for several reasons: 1) RGS4 has been reported to
co-immunoprecipitate with µ- and δ-opioid receptors from periaqueductal gray
membranes (Garzon et al., 2005), 2) the functional impact that precoupled RGS4
has in contrast to uncoupled RGS3s in the Xenopus oocyte experiments once
the protein concentration of both RGS was reduced and tritated 3) The
precoupling is RGS protein specific, being only RGS4 able to associate to the
different GPCR-GIRK channel complexes.
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Figure 6.1. Differential coupling of RGS proteins to GPCR-GIRK channel
signaling complexes. (A) RGS4 couples to GPCR-GIRK channel signaling
complexes, interacting with the GPCR and not with the GIRK subunit. (B) RGS3s
does not couple to the GPCR-GIRK channel signaling complexes.
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